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ABSTRACT   
 
Toxoplasma regulates its gene expression throughout its complex life cycle to survive and 
confront different kind of stresses. Here I aimed to gain a better understanding of how this 
regulation is maintained in Toxoplasma at the post-transcriptional level and in the aspect of the 
formation of messenger ribonucleoprotein complex (mRNPs). I chose to study the poly(A) 
binding protein (PABP). Metazoans usually encode multiple isoforms of PABP to function in 
nucleus and/or cytoplasm but in Toxoplasma there is only one predicted PABP. In this thesis, I 
studied the localization of the only predicted PABP in Toxoplasma (TgPABP). It was detected 
that TgPABP is predominantly localized in the cytoplasm under treatment with actinomycin D. 
Second, we also found that TgPABP aggregates into microscopically visible granules, as an 
indicative of mRNPs. Upon salubrinal treatment, mRNPs were formed in both extracellular and 
in intracellular parasites whereas cycloheximide can diffuse these granules in less than one hour.  
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CHAPTER I 
LITRATURE REVIEW 
 
 
1.1 The discovery of Toxoplasma gondii 
 
T. gondii, a single eukaryotic cell organism, belongs to the apicomplexan phylum. About 
5000 members of parasites have been discovered under this phylum. Diverse life-threatening 
diseases in both humans and animals have been attributed to many members of Apicomplexa 
(Zhou et al. 2011). Among all species in this phylum, the members of Plasmodium and 
Toxoplasma genus are the causative agents of malaria and toxoplasmosis, respectively. Both 
infections are prevalent worldwide. T. gondii is the only species in the genus and is an obligate 
intracellular parasite (Dubey, 2012). It is widespread in most parts of the world because it can 
infect any warm-blooded organism (Sullivan and Jeffers, 2012). The discovery of T. gondii was 
in 1908 by Nicolle and Manceaux. They initially found this protozoan parasite in a hamster-like 
rodent called gundi in Tunis (Dubey, 2012). 
Even though T. gondii was discovered in 1908, the elucidation of its life cycle and 
diseases that it caused were not known until the year 1970 (Hutchison et al., 1978). The first 
diagnosed case with toxoplasmosis in human was recorded in 1939, when an infant died after 
three days of birth (Wolf et al., 1939). Approximately one-third of the world’s population is 
infected by T. gondii as per the latest data (Dalimi and Abdoli, 2012). The percentage of 
seroprevalence of infectivity is diverse worldwide; and it depends upon some factors such as 
nutritional and socio-cultural habits (Hill et al., 2005). For instance, in the US the prevalence of 
seropositive to T. gondii is between 16 – 40%. In some other countries, however, the prevalence 
is much higher. In Canada, specifically in Nunavut and Quebec, it was reported to exceed 80 % 
(Hill et al., 2005).  
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1.2 History  
 
In addition to being discovered in the tissue of Ctenodoactylus gundii, T. gondii was also 
discovered in the rabbit tissues by Alfonso Splendore in Brazil in the same decade (Weiss and 
Dubey, 2009). A T. gondii-like parasite was described in blood and spleen smears in 1914 
(Weiss and Dubey, 2009).  The samples were taken from a boy suffering from severe anemia, 
splenomegaly, and fever. Similar findings were found in a boy with similar symptoms two years 
later; also, another similar case in 1920 was reviewed. Whereas all three of these cases could 
have been toxoplasmosis, the first case directly attributable to T. gondii was identified in 1923 
(Warren and Cohen, 1982). 
T. gondii was first confirmed as a source of human disease in 1939 (Wolf et al., 1939). At 
that time, a baby died at the age of one month, and an autopsy revealed both free and 
intracellular T. gondii parasites. Samples of brain and spinal tissues of the baby were injected 
into test rabbits and mice. The animals that were inoculated with diseased tissues developed 
toxoplasma symptoms. T. gondii isolated from these infected animals were then passed to other 
animals that too developed the same symptoms, proving that the disease was infectious (Weiss 
and Dubey, 2009). 
 
1.3 Life Cycle of Toxoplasma gondii 
 
There are two main branches of multiplication forms of T. gondii, sexual and asexual 
reproduction (Figure 1.1). The sexual branch is one that takes place only inside of a feline host, 
and that is why the cats are identified as the definitive host. The second branch in the lifecycle is 
asexual. It can occur within any type of warm-blooded animals. The host which allows asexual 
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multiplication is called the intermediate host (Dubey et al., 1998).  Common forms of T. gondii 
to transmit infections are sporulated oocysts, tachyzoites, and bradyzoites.  
1.3.1 Sexual stage 
 
T. gondii passes through the stomach of the cat with no damage from stomach acids; it 
reaches the epithelial lining of the intestines which serves as the site for sexual multiplication 
and development (Dubey et al., 1998). Then, it develops the microgametocytes or 
macrogametocytes, which is male or female germline, respectively. After which, zygotes are 
produced in the millions from the combination of both germlines to develop further into oocysts.  
Subsequently the oocytes are shed in the feces and spread into the environment (Ferguson and 
Dubremetz, 2007). T. gondii can also be transferred via the fecal/oral route back to the cat. 
Oocysts (10 x 12 µm), which leave the feline, can survive in the environment for a long period in 
the form of sporozoite (Torrey and Yolken, 2013). The sporozoites are produced within 21 days 
after the oocysts are shed and are the infectious form to infect other intermediate hosts, including 
mammals, birds and any worm-blooded organisms. When sporozoites are eaten by an 
intermediate host, they develop into the rapid replication form, tachyzoites. Once tachyzoites 
start multiplication, the asexual form of life cycle is initiated (Montoya and Liesenfeld, 2004). 
 
1.3.2 Asexual stage 
 
 The asexual life cycle of T. gondii is represented by the replication of tachyzoites and 
bradyzoites. Once the tachyzoite enters the intermediate host’s cell, it creates parasitophorous 
vacuoles (PV) to surround and protect itself (Dubey et al., 1998). Within protecting PV and 
through the development process called endodyogeny, each tachyzoite multiplies with after ∼ 6-8 
hours doubling time, and eventually the enlarging PV size forces the cell to rupture or lyse. 
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When the host cell is ruptured, the tachyzoites are released. Once released, they have free access 
to infect other cells throughout the host body via the bloodstream. The free floating tachyzoites 
typically infect muscles, brain tissues, and eyes (Dubey et al., 1998). As millions of tachyzoites 
invade a healthy host, an immune response is triggered. The host’s immune system cause the 
conversion of tachyzoites to bradyzoites. Bradyzoites are the latent form/stage of asexual 
replication. Their structure is similar to that of tachyzoites, but their replication is much slower. 
They are known as clusters of tissue cysts (Dubey et al., 1998) which can be found in meat 
products. The tissue cysts are ∼5 to 50 µm in diameter, and are common causes of an infection in 
humans when they consume contaminated or uncooked meat product (Centers for Disease 
Control, 2015). 
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Figure 1.1 Diagram summarizing the life cycle of T. gondii. A sexual cycle occurs within 
intestinal cells of felines, while an asexual cycle occurs in mammals, birds, and almost in any 
worm-blooded organisms. Sporulated oocyst reaches the intermediate hosts through 
ingestion. The multiplication of Toxoplasma gondii is either acute, quickly replicating 
tachyzoites, or chronic infection is representative of encysted bradyzoites, that remain 
dormant for the lifespan of the host. This image was obtained from Ferguson (2009). 
 
 
 
 
 
 
Tissue cyst 
Tachyzoites 
in a PV 
Oocyst 
7 
 
1.4 Toxoplasma genotypes 
 
Minot et al. (2012) demonstrated that the variation in the genetic of different strains of T. 
gondii determines their virulence, multiplication, distribution and severity of diseases in mice. 
There are multiple types of T. gondii: Type I or RH, Type II or ME 49, and Type III or VEG. At 
the nucleotide level, the similarities of sequences are as high as 98% identical (Saeij et al., 2005). 
Yang et al. (2013) described Type I as the most common strain. According to a study completed 
in 2008, out of all cases of T. gondii found in the United States, Type II was found to be most 
abundant. Both Types I and II are highly prevalent in Europe, North America, and Africa (Sibley 
et al., 2009). In comparison to Type I, Type II and III strains are avirulent. The Type I strain was 
proven to be deadly in mice, but other animals experienced a non-disease infection. These and 
other similar animal experiments have proven that the genetic background of a species has a 
strong influence on the genotypic expression of the Toxoplasma’s virulence (Khan et al., 2005). 
Type I is most prevalent in severe cases of Toxoplasma infection. With people who are 
immunocompetent, there is an unusual abundance of Type I genotypic versions of T. gondii 
(Araujo and Slifer, 2003). 
 
1.5 Toxoplasmosis symptoms  
 
Toxoplasmosis is characterized by flu-like symptoms, which include swollen lymph 
nodes, muscle aches, and fever. The duration of the initial symptoms can last for a short period 
of time and then become asymptomatic. In healthy individuals with strong immune system, the 
infectious tachyzoites are converted to bradyzoites, the latent stage, and as a result the clinical 
symptoms, disappear (Montoya and Liesenfeld, 2004). People who are immunosuppressed due to 
HIV/AIDS or chemotherapy treatments, are more susceptible to this disease (Montoya and 
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Liesenfeld, 2004). If no treatment is given, the patient can develop severe infections that lead to 
organs impairments. For example, ocular toxoplasmosis is developed, when the parasites reach 
the eyes and could cause partial blindness (Mullens, 1996). Congenital toxoplasmosis could lead 
to seizures and reduce brain function (Mullens, 1996). 
 Treatment of the rapid replication form, tachyzoites, is available for T. gondii parasitic 
infection. It is the combination of pyrimethamine and sulfadiazine, and they are typically 
prescribed for T. gondii infection. These drugs are effective for killing tachyzoites before 
destroying tissues. However this drug regimen is less effective towards the tissue. The side 
effects, including toxicity to bone marrow and allergy, make these drugs unsuitable for the long 
term treatment (Ferguson, 2009). Also, these drugs could cause birth defects and may pass the 
placental barrier to infants (Centers for Disease Control, 2015). 
 Understanding the regulation of gene expression may help leading for discovery of new 
drugs to treat toxoplasmosis. Therefore, we will review the gene expression in eukaryotes in the 
next section.   
1.6 The regulation of gene expression 
 The essence of gene expression is turning the gene on and yielding a product; and the 
regulation is ensuring the proper level of its expression for the cellular survival. The product 
usually is a molecule that used in regulation, such as an enzyme, or a protein that is involved in 
the structure of the cell. Also, the product is involved in the synthesis, assembly, and localization 
of transcripts in the cell (Halbeisen et al., 2008). Studies of gene expression focus on different 
stages including: transcriptional and post-transcriptional of transcripts, its stability, and 
translational regulation. Here, we review in particular transcriptional and post-transcriptional 
regulation. 
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1.6.1 Transcriptional and Post-transcriptional regulations 
 Multiple transcriptional factors exist to maintain the levels of transcripts that are 
necessary for the growth and development of the cell; these factors are proteins in nature (Starr et 
al., 2014). Their influences on genes occur through the binding to DNA and either enhancing or 
repressing the process of transcription. Activators increase the rate of transcription by recruiting 
the RNA polymerase to bind DNA.  On the other hand, repressors bind to a silencer sequence or 
a promoter; therefore blocking the initiation of transcription (Starr et al., 2014). In eukaryotes, 
some transcriptional factors obstruct genes to be affected by enhancers or silencers by binding to 
sequence of DNA known as insulators. An example of these factors is the histone. Histones bind 
around the DNA in nearly all eukaryotes. In order for RNA polymerase to access and interact 
with DNA, histones must be unwound (Starr et al., 2014).   
 Modifications of histones also control transcription through increasing their grasp of 
binding or releasing from DNA. Addition of an acetyl or a methyl group is an example of 
histones modifications. In Toxoplasma, histone 3 (H3) and histone 4 (H4) are known to be 
modified by additional of an acetyl group, by acetyltransferase, to activate the transcription and 
its removal for deactivation. Likewise, methytransferases add a methyl group to H3 or H4 to 
activate the transcription (White et al., 2007).  
 In the nucleus, preceding exportation of transcripts to the cytoplasm, three post-
transcriptional modifications are applied on pre-mRNA including: addition of the 5ʹ cap, splicing 
introns out, and generating a polyadenylated tail at the 3ʹ end.   
 Capping mRNAs at the 5ʹ end is a vital step in the gene expression (Furuichi and Shatkin, 
1989). The cap structure is added following the synthesis of nearly 25 nucleotides. Its assembly 
starts with cleavage of the triphosphate group to diphostphate of the first nucleotide by the RNA 
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5ʹ triphosphatase. Then, it is followed by transferring of a guanyl residue to the 5ʹ terminal by 
guanylyltransferase which result in an unusual linkage between nucleotides (5ʹ – 5ʹ) in the 
mRNA. Finally, a methytransferase transfers a methyl group at the N7 position of GMP 
(Proudfoot and Furger, 2002). Furuichi and Shatkin (1989) noted that these modifications result 
in the stability of the transcripts through hindering 5’-3’ exonuclease activities. The capping 
structure recruits CBP20 and CBP80, known as cap binding complex (CBC), for exporting the 
transcripts to cytoplasm. The CBC then is replaced with the initiation factor 4E (eIF4E) in the 
cytoplasm which triggers the development of the translational apparatus (Proudfoot and Furger, 
2002).      
The next process of modification and maturation is the splicing out non-coding sequences 
from pre-mRNA known as introns. These sequences are located between mRNA coding 
sequences. For the splicing reaction to occur, cis-components are required, which are the 5ʹ – 3ʹ 
exon-intron connection. The 5ʹ splice site is marked by AG|GURAGU while 3ʹ YAG|RNNN (| 
indication for spliced sites) (Proudfoot and Furger, 2002). The researchers also demonstrated that 
the branch-point is located upstream of the 3’ intron-exon junction. The process of splicing takes 
place in two steps: removing introns and joining between exons. Through the assembly of the 
splicesome, which contains five small RNAs and several other proteins, splicing is facilitated 
(Proudfoot and Furger, 2002).  
 The formation of the 3ʹ end polyadenylated tail is the last step of the mRNA maturation 
process occurring in the nucleus. To allow addition of the poly(A) tail, pre-mRNA must be 
cleaved between the downstream sequence element, U and GU-rich sequence, and a highly 
conserved sequence which is AAUAAA. First, two proteins, cleavage factor I and II, bind to and 
cleave the pre-mRNA. Specifically, the cleavage occurs between CA dinucleotide (Proudfoot 
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and Furger, 2002). Then, poly(A) polymerase (PAP), cleavage and polyadenylation specificity 
factors are recruited and initiate the formation of adenosine residues. A protein known as 
poly(A) binding protein II functions to accelerate the polyadenylation at this step.  
Approximately 200 adenosine residues are added by PAP (Proudfoot and Furger, 2002). These 
residues are essential for the mRNA processing (Zhao et al., 1999). Competition of this process 
results in the production of mature mRNAs that are ready for exportation to the cytosol. Various 
proteins bind to the mature mRNA to help in exporting and localizing of the transcripts.  
 In the cytoplasm, various proteins bind to mRNA and regulate its fate. Typically, a 
transcript is subjected to translation and produces a protein through the recruitment of 
translational machinery. Briefly, the initiation of translation occurrs in three steps: i) recruitment 
of the ribosome to the mRNA, ii) placing a charged tRNA into the P site of the ribosome, and iii) 
positioning of the ribosome on the start codon AUG (Watson et al., 2003). However, 
untranslated transcripts may have a different destination for storage or degradation processes in 
subcellular structures known as messanger ribonucleoproteins (mRNPs) (Souquere et al., 2009); 
it will be reviewed in detail below. The maturation process of mRNAs is illustrated in (Figure 
1.2). 
 Both structures, the 5ʹ cap and poly (A) tail are essential parts of mRNA for the initiation 
of translation. Cap-dependent translation starts by the binding of the eukaryotic initiation factor 
4F (eIF4F) complex. The composition of this complex is eIF4E, eIF4A (a DEAD-box helicase), 
and eIF4G (Sonenberg and Hinnebusch, 2009). eIF4E is a cap-dependent protein that has a 
specific affinity for the 5ʹ cap (m7GTP-N where N is any nucleotide) even in the absence of ATP 
(Sonenberg and Hinnebusch, 2009). eIF4E is believed to function in the developmental stages 
and proliferation in certain cells. Also, it has been noted that the expression of eIF4E protein is 
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increased in cancerous cells (Pettersson et al., 2014). Furthermore, eIF4E interacts with eIF4G 
that results in formation of a specific eIF4F. eIF4G interacts with poly(A) binding protein 
(PABP) which binds to poly(A) tail and subsequently the mRNA closed-looped structure is 
formed (Sonenberg and Hinnebusch, 2009). Upon interaction of 5ʹ factors and 3ʹ components 
that circularize mRNA, the recruitment of the pre-initiation complex is facilitated. The closed-
loop helps in the recruitment of the polysomal complex, small ribosomal 40S subunit and the 
initiation factors which include Met-tRNAi and eIF2-GTP. Once the AUG is found through 
scanning, eIF2-GTP is hydrolyzed to eIF2-GDP which recruits 60S ribosomal subunits and 
proceeds for translation elongation (Sonenberg and Hinnebusch, 2009).  
 
 
Figure 1.2 The mRNA maturation process in eukaryotes.  This diagram is summarizing the 
mRNA processing. In the nucleus, the 5ʹ cap is added to pre-mRNA, introns are spliced out, and 
the addition of 3ʹ Poly (A) tail is occurred. This image was obtained from (Neugebauer, 2002). 
 
Just as in other eukaryotes, T. gondii sustains localization and stages of the cytoplasmic 
mRNAs and this process is also considered as a post-transcriptional regulation. Throughout the 
life cycle of Toxoplasma, a precise control of gene expression takes place to ensure the 
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appropriate regulation of maturation and proliferation of the cell. One of the common identified 
and well-studied protein that is involved in gene regulation at the initiation of translation is the 
initiation factor 2 α (eIF2α) (Zhang et al., 2010). eIF2 consists of three subunits α, β, and γ. The 
inactive form (eIF2-GDP) unbound from 40S ribosomal subunit and is exchanged to eIF2-GTP 
which will allow another cycle of initiation to start. However, when the cell undergoes stress, 
eIF2α is phosphorylated and the form eIF2α-P blocks the exchanging to eIF2-GTP which 
eventually stops the protein synthesis (Zhang et al., 2010). Four distinct eIF2α kinases have been 
discovered in mammals and they are activated according to types of cellular stresses. In 
Toxoplasma, the serine residue 71 of TgIF2 (T. gondii eIF2) is subjected to phosphorylation 
(Zhang et al., 2010). Joyce et al. (2010) demonstrated that a mutation in S71A resulted in the 
reduction of viability of Toxoplasma once extracellular and slows the replication in a newly 
invaded host. Similar observations were seen in the TgIF2K-D kinase strain. TgIF2K-D is a 
kinase that functions to phosphorylate eIF2 in Toxoplasma. Moreover, it was noted that nutrient 
deprivation induces and elevates TgIF2α-P (Zhang et al., 2010). Following inhibition of 
translation, stalled transcripts then accumulate into cytoplasmic foci or mRNPs granules (Lirussi 
and Matrajt, 2011).      
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1.7 Structure and functions of mRNPs 
 
 Untranslated mRNAs with numerous of their interacting proteins, and small non-coding 
RNAs (ncRNAs) are typically the major components of eukaryotic mRNPs (Mitchell and Parker, 
2014). In general, mRNPs aggregate in larger granules that can be detected under the 
fluorescence microscopy (Mitchell and Parker, 2014). mRNPs can be found in both the nucleus 
and the cytoplasm. Some of the nuclear subcellular structures are transported to the cytoplasm 
either by passing through the nuclear pore or in case of larger mRNPs they exit throughout 
budding process (Müller-McNicoll and Neugebauer, 2013). Cytoplasmic mRNPs then go 
through remodelling of their components either for translation to occur or shift for other types of 
mRNPs (Mitchell and Parker, 2014). mRNPs are variable in their components, functions, and co-
localization according to the cell needs. Herein, it is necessary to review the types of cytoplasmic 
mRNPs and their significance in gene regulation particularly neuronal transport RNP granules, 
sponge bodies, U bodies, TAM bodies, RNP-rich cytoplasmic germline granules, GW or 
processing bodies, and stress granules. 
1.7.1 Neuronal transport RNP granules: 
 Even though some of these type of granules may be irrelevant to mRNPs in Toxoplasma, 
but it is of importance to mention for revealing the different functions of mRNPs. Neuronal 
transport RNPs are non-membranous cytoplasmic 0.15 to 1 µm sub-organelles (Moser and 
Fritzer, 2010). They have been studied in mammalian and fruit fly neurons. These granules can 
be identified by the presence of two proteins: Staufen which is a double-stranded RNA binding 
protein, fragile X mental retardation protein. Also many other molecules accumulate in this 
granule that involved in active translation and translational inhibition (Moser and Fritzer, 2010). 
In neuron cells, the composition of mRNPs is important in the control of regulation of 
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development of the cell and plasticity through transporting mRNAs to a certain location for 
translation, or storage (Moser and Fritzer, 2010).   
1.7.2 Sponge bodies: 
 Sponge bodies were discovered in 1988 in Drosophila nurse cells and oocytes and their 
size range from 0.5 – 3 µm (Berleth et al., 1988; Snee and Macdonald, 2009). These granules are 
identified by the enrichment of Exuperantia protein which functions to localize specific mRNAs 
to specific sites in oocytes (Moser and Fritzer, 2010). Snee and Macdonald (2009) highlighted 
that the composition of sponge granules were variable under optimal and less experimental 
conditions (for complete list of compositions, review Snee and Macdonald, 2009).  This finding 
indicated that sponge granules have a role in post-transcriptional regulation (Moser and Fritzer, 
2010).  
1.7.3 U bodies: 
 Uridine-rich small nuclear ribonucleoproteins bodies (U bodies) have been described in 
fruit fly, murine, and human cells as cytoplasmic granules 0.2 – 0.4 µm that contain U1, U2, 
U4/U6 and U5 (U snRNPs) (Liu and Gall, 2007). snRNPs are involved in splicing out introns in 
the nucleus. Moreover, disruption of P bodies (reviewed in detail below) components led to the 
disassembly of U bodies (Liu and Gall, 2007).  
1.7.4 RNP-rich cytoplasmic germline granules: 
 Cytoplasmic germinal granules 0.2-0.9 µm (also known as chromatoid bodies) have been 
discovered in more than 80 species and mostly studied in D. melanogaster, C. elegans, and X. 
laevis (Moser and Fritzer, 2010). Germ granules are localized in the cytoplasm peripheral to the 
nuclear envelope and mitochondrial clusters. In germ and somatic cells, these granules are key 
factors in germ cell development and early stages of embryogenesis. It was demonstrated that 
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germ granules involved in processing, degradation, repression and long-term storage of mRNAs 
(Moser and Fritzer, 2010; Joyce et al., 2013; Sengupta and Boag, 2012). These regulatory 
processes are determined by their composition including mitochondrial proteins, histone, and 
ubiquitin-related protein components (Moser and Fritzer, 2010). In Toxoplasma, it was suggested 
that these granules maybe exist as a control mechanism to protect and preserve certain types of 
mRNAs that were repressed in bradyzoites before converting to tachyzoites (Holmes, 2015).   
1.7.5 Processing bodies (P bodies): 
 P bodies (also in metazoan called GW182 granules due to the presence of 182 kDa 
protein rich in glycine and tryptophan) were reported first in mouse E10 cells (Moser and Fritzer, 
2010). Immunogold electron microscopy revealed that these granules are 0.1 – 0.3 µm diameter 
and were not limited by a membrane (Moser and Fritzer, 2010). P bodies have been identified in 
S. cerviceae, D. melanogaster, C. elegans, and in various types of cells in mammals (Parker and 
Sheth, 2007). Aggregation of P bodies were found to be variable in size and number in cancer 
cells, at different stages of cell cycle, stress responses, and inhibition of transcription and 
translation (Moser and Fritzer, 2010).  Indirect immunofluorescence (IIF) and western blot 
analysis revealed the composition of P bodies including: miRNA, proteins involved in 5ʹ to 3ʹ 
mRNA degradation pathway, proteins involved in the silencing pathways, and other factors 
involved in mRNA stabilization, transportation, and processing (Moser and Fritzer, 2010).  
 The protein components of P bodies may reflect some of their functions which include 
degradation of mRNAs and/or storage of translationally repressed transcripts as it was evident by 
the presence of miRNA and proteins involved in repression such as Ago, PUF, TTP, and DHH1 
(Parker and Sheth, 2007). Multiple pathways exist for the degradation of mRNAs. However, 
transcripts in P bodies are more likely to be degraded from 5ʹ to 3ʹ. This process starts by 
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shortening the poly(A) tail and excluding its interaction protein (PABP). Then the decapping 
machinery (Dcp1/2) hydrolyzes the 5ʹ cap m7Gppp followed by degradation by Xrn1 
exonuclease (Parker and Sheth, 2007). Although formation of P bodies is said to be ubiquitous, 
their expression are increased in cells that undergo stresses (Moser and Fritzer, 2010; Anderson 
and Kedersha, 2008). Also, repressed mRNAs could re-enter the initiation pool after 
polyadenylation of the 3ʹ tail by the cytoplasmic poly (A) polymerase (Godwin et al., 2013). 
Intriguingly, Toxoplasma has Dcp1/2 proteins and other markers for P bodies. 
1.7.6 Stress granules: 
 Stress granules (SGs) are relatively larger cytoplasmic aggregates compare to other 
granules (0.1 – 2.0 µm). These granules have been shown in various organisms including 
mammalian cells and protozoa. The formation of SGs is induced upon environmental stresses as 
heat shock, starvation, and oxidation (Anderson and Kadersh, 2009). 
 SGs are rapidly assembled upon induction of stresses. SGs are a way for the cell to 
protect and store untranslated mRNAs (Moser and Fritzer, 2010; Anderson and Kadersh, 2009). 
First, the phosphorylation of eIF2α or inactivation of eIFs causes the release of polysomes and 
stalled translation of mRNAs. Notably, eIF2α-P reduces the availability of the eIF2α-GTP-Met-
tRNAi complex to initiate the translation; as a result, translation is blocked (Anderson and 
Kadersh, 2009). Next, primary aggregation of SGs is enhanced by interaction of SG-nucleators 
with the 48S ribosomal subunit (Anderson and Kadersh, 2009). Other proteins then recruited and 
bind to either 5ʹ UTR or 3ʹ UTR which ultimately lead to larger aggregation of SGs to become 
visible under microscopes (Anderson and Kadersh, 2009).  
 SGs share many components with others types of granules but the core composition are 
the small ribosomal subunit 48S, initiation factors eIF3 and 4, and PABP. Also, they have other 
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classes of proteins known to function in translational silencing for example (T-cell internal 
antigen-1 or TIA-1) (Anderson and Kadersh, 2009). Repressed mRNAs in SGs have different 
fate including: remain stored, re-enter to polysome for translation, or shuttle to other granules 
such as P bodies for degradation (Voronina et al., 2011). Major destinations of mRNAs are 
summarized in Figure 1.3. 
 SGs were detected in T. gondii by tracking PABP protein (Lirussi and Matarjt, 2011). 
They use a commercial antibody which was produced against human PABP, which shares high 
similarities at amino acids sequences level with its homolog in Toxoplasma. To confirm the 
formation of these granules, they used some treatments known to influence on the formation of 
SGs such as salubrinal and cycloheximide (Lirussi and Matarjt, 2011). SGs were visualised in 
extracellular parasites but not in intracellular (Lirussi and Matarjt, 2011). The negative detection 
for SGs in the intracellular parasites maybe due to the unspecific antibody they used to detect 
TgPABP. They used an antibody raised against human PABPC1 and the cells which were used 
to propagate the parasites also human cells. This maybe a possible reason that they could not 
detect intracellular SGs.  
 Another protein was also pointed to be a compartment of SGs in Toxoplasma is TgHoDI 
(Toxoplasma gondii Homolog of DOZI) (Cherry and Ananvoranich, 2014). TgHoDI is an RNA 
helicase that involves in regulation of mRNAs. TgHoDI was shown as a marker for the 
cytoplasmic SGs in Toxoplasma. Granules containing TgHoDI were accumulated in larger 
aggregates when parasites underwent stresses (Cherry and Ananvoranich, 2014).    
 As previously mentioned mRNPs are highly regulated through protein-RNA interactions. 
These interactions occurred by binding of domains of proteins known as RNA-binding proteins 
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(Moser and Fritzer, 2010). Herein, due to their involvement in post-transcriptional regulation, we 
will briefly review these domain structures, functions, and their specificities.   
 
 
Figure 1.3 Pathways of mRNAs in eukaryotes. Once exported to cytoplasm, the fate of mRNA 
is varied including i) ribosomes, ii) exosomes, or iii) mRNPs. Major types of mRNPs are P 
Bodies, and Stress Granules. SGs is the aggregates that protect mRNAs from degradation while 
P bodies may serve as a place for degradation. This image was obtained from (Parker and Sheth, 
2007). 
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1.8 The RNA-binding proteins (RBPs) 
 
 RBPs modulate mRNA from its synthesis in the nucleus to degradation in the cytoplasm 
(Glisovic et al., 2008). These proteins can recognize and bind single and double stranded RNAs 
at the primary structure or at the three dimensional structural levels (Gerstberger et al., 2014). It 
is important to note that RBPs interact with any of the RNA structures. The proteins under this 
family (RBPs) are consisting of RNA binding domains (RBDs) and auxiliary domains which 
have impacts on the binding activities of protein-RNA and also protein-protein interactions 
(Glisovic et al., 2008; Gerstberger et al., 2014). RBPs could contain one or multiple RBDs. 
Initial studies on characterization of these proteins were in 1970s, and they were named 
heterogeneous nuclear ribonucleoprotein (hnRNP) (Gerstberger et al., 2014). At present, RBPs 
are subdivided into groups according to their domains (Gerstberger et al., 2014).   
 Proteins containing RNA recognition domains (RRMs) are abundant in cells and consider 
as a well-studied domain compared to other RBDs. The secondary structure of RRM is βαββαβ. 
Each RRM consists of approximately 90 amino acid residues (Glisovic et al., 2008). Conserved 
sequences are located within RRM1 and RRM2 of RBPs known as RNP1 and RNP2, K/R-G-
F/Y-G/A-F/Y-V/I/L-X-F/Y and I/V/L-F/Y-I/V/L-X-N-L respectively. RRMs can interact with 
specific target consisting of 4 – 8 nucleotides of ssRNA or ssDNA (Gerstberger et al., 2014). 
PABP and TIA-1 are examples of proteins that consist of multiple RRMs and TIA-1 has been 
shown in human cells to function in the formation of mRNPs (Tessier et al., 2014). Notably, in 
the Toxoplasma genome at least 86 genes are annotated to encode proteins containing RRMs 
(ToxoDB.org). Other important RBDs known to play a vital role in post-transcriptional 
regulation such as K-homology (KH) domain, Zinc finger, DEAD/DEAH box helicases, Pumilio 
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(PUF), Piwi/Argonaute/Zwille (PAZ) domains (Lee and Schedl, 2006). In table 1.1 is the 
summary for the structures, functions, and targets. 
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Table 1.1: Characteristics of RBDs 
 
  
 
 
 
RBDs structure Consensus 
sequence 
Functions in 
gene regulation Target Examples References 
RRM 
 
(90 amino acids) 
βαββαβ barrel-
like 
 
RNP1: K/R-
G-F/Y-G/A-
F/Y-V/I/L-
X-F/Y 
RNP2: 
I/V/L-F/Y-
I/V/L-X-N-
L 
Translational 
activator. 
Cytoplasmic 
poly(A) element 
binding 
 
ssRNA 
or 
ssDNA  
 
hnRNP 
A1 
(UAGG) 
PABP 
(AAAA) 
Glisovic et 
al., 2008; 
Lee and 
Schedl, 2006 
KH 
 
(70 amino acids) 
Three-stranded β-
sheet packed 
against three α-
helices   
 
(I/L/V) 
IGXXGXX(
I/L/V) 
present in 
the middle 
of domain 
Translation 
Splicing 
Chromatin 
remodelling 
ssRNA 
or 
ssDNA 
SAM68 
QKI 
Glisovic et 
al., 2008 
Zinc-finger (30 amino acids) 
ββα structure 
C-x8-C-x5-
C-x3-H 
Translational 
activator / 
repressor 
dsRNA TFIIIA Tra-1 
 
Gerstberger 
et al., 2014 
 
PUF 
(40 amino acids) 
three α-helices 
that pack together 
into a half-ring 
structure. 8 
repeats is present 
on each PUF.  
unknown 
Translational 
repressor 
mRNA stability 
and translation 
(3ʹ UTR 
RNA) 
binds to 
(UGUA
NAUA) 
Pumilio 1 
and 2 
Gerstberger 
et al., 2014 
DEAD box 
helicases 
(400 amino acids) 
Domain 1 and 
domain 2 
DExD/H 
Unwinding RNA 
secondary 
structures 
dsRNA eIF4A Gerstberger 
et al., 2014 
PAZ 
(110 amino acids) 
β-barrel followed 
by αβ-domain 
unknown 
Post-
transcriptional 
silencing of 
mRNAs 
microRNA 
or RNA 
backbone 
Piwi 
Argonaute 
Dicer 
Gerstberger 
et al., 2014 
23 
 
1.9 Poly(A) binding protein 
 
 Eukaryotic PABPs play a central role in stability an d translation of mRNAs through 
binding with high affinity to its poly (A) tail tract (Wigington et al., 2014; Smith et al., 2014). 
The length of poly (A) tail is varied from organism to another but generally it consists of 90 – 
250 adenosine residues (Goss and Kleiman, 2013). In metazoans and specifically in human, 
various isoforms of PABP have been identified. At least one isoform is found in the nucleus, and 
it is called PABPN1 (N for nuclear) which has one RRM domain and arginine rich at the C-
terminus end (Goss and Kleiman, 2013). In the cytoplasm, four versions of PABPs were 
identified (PABPC1, PABPC3, iPABP, and PABPC5) (they were reviewed in Mangus et al., 
2003). PABPC1 and PABPC3 are closely related isoforms but PABPC1 has higher affinity to 
bind to mRNAs. The expression of these analogs differs according to the cell types and stages 
 (Eliseeva et al., 2013). Also, eight PABPs encoded in the genome of Arabidopsis thaliana were 
identified (Goss and Kleiman, 2013).  
 On the other hand, Goss and Kleiman (2013) stated that single eukaryotic cell such as 
yeast and protozoan are typically encoding one PABP. This is true in the case of S. cerevisiae but 
some protozoans have been shown to encode multiple isoforms as in case of Trypanosomes, 
Leishmania, and Plasmodium (Kramer et al., 2013; Lima et al., 2010; Tuteja 2009). However, in 
the Toxoplasma genome, it is predicted to encode only one PABP. PABPC1 is conserved in most 
eukaryotic cells including protozoan.  
1.9.1 Structure of PABPC1:  
 The structure of PABPC1 consists of four highly conserved RRMs at the N-terminal end 
and a less conserved PABC at the C-terminus (Burd and Dreyfus, 1994). The structure of RRMs 
is βαββαβ, and they are linked by a few residues while a long linker rich in Proline and 
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Methionine residues were found between the last RRM and PABC (poly(A) binding protein C-
terminus) (Mangus et al., 2003). PABC interacts with other proteins but not with RNA. The 
auxiliary domain PABC structure is composed of four to five α-helices. The structural diagram 
of PABPC1 is shown in (Figure 1.4).  
 About 12 adenosine residues poly(A) tail are required for the interaction with PABP. The 
majority of this interaction occurred in the two central β sheets of RNPs for PABP (Mangus et 
al., 2003). RRM1 is identical to RRM3 whereas RRM2 is identical to RRM4 and RRM1/2 
represents one functional unit while RRM 3/4 another functional unit (Deo et al., 1999). The first 
unit RRM1/2 binds with high affinity to poly(A) tail. RRM3/4 cannot bind to the same 
transcripts but it is important in binding to other transcripts (Deo et al., 1999). Deo and 
colleagues demonstrated that RRM2 bound to about 4 adenosines at the 5ʹ end and RRM1 
interacted with another 4 adenosines at 3ʹ. Also, the linker in between RRM 1 and 2 was bound 
to 2 residues as it was determined by x-ray crystallography (Deo et al., 1999). PABC is made of 
about 75 amino acids and it is an independent unit (Koslov et al., 2001). This domain contains 
consensus sequences known to interact with other proteins involved in translation as Paip1 and 
Paip2, and eRF3 (Koslov et al., 2001).    
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Figure 1.4: Molecular structure of PABPC1 domains. (A) A diagram to show the four RRMs 
and the PABC domains. (B) Tertiary structure of RRM1/2 bound to poly(A) tail. (C) PABC 
domain. C and D were obtained from Mangus et al., 2003; and Koslov et al., 2001, respectively.  
 
 
 
 
 
 
 
 
NH2 COOH 
RRM1 RRM2 RRM3 RRM4 PABC 
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1.9.2 Cellular functions and localization of PABP:  
 PABP is a scaffold protein that binds to specific sequences of mRNA and interacts with 
other proteins to modulate the fate of mRNA and therefore regulate gene expression (Goss and 
Kleiman, 2013; Eliseeva et al., 2013). More importantly Burd et al. (1991) showed that the 
localization of PABP is indicative of polyadenylated mRNAs since PABPs predominantly bind 
to the poly (A) tail of the transcripts. In the nucleus, PABPN1 enhances the polyadenlylation 
process by interaction with PAP and cleavage and polyadenylation specificity factor (CPSF). 
Also, it functions to protect the mRNA from 3ʹ exonucleases activity and export to the cytosol 
(Eliseeva et al., 2013). Once in the cytoplasm, as it was discussed in previous section PABP 
contributes in bringing the 3ʹ end of mRNA to 5ʹ cap through interaction with eIF4G to make the 
closed-loop structure and promote the translation (Haar et al., 2000). Furthermore, PABP is 
involved in the stability and degradation of mRNA through interaction with eRF3, translation 
termination factor 3 (Eliseeva et al., 2013). Interaction between PABP and eRF3 reduces the 
affinity of binding to the 3ʹ end and as a result poly(A) tail is shortened to 10 – 15 adenosine 
residues. This will initiate the mechanism of mRNA degradation (Mangus et al., 2003). These 
functions are illustrated in (Figure 1.5).    
 
 
 
 
 
 
Figure 1.5 Representation of the involvement of PABPs in the gene regulation.  This figure 
summarized the PABP function including: its involvement in the decapping process, stabilization 
and degradation of mRNAs. The figure was modified from (Eliseeva et al., 2013). 
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 In S. cerevisiae, there is only one gene encoded for PABP and it is vital for the survival 
of the cell. Sachs and Davis (1989) revealed that reduction in the level of PABP resulted in 
deficient in the recruitment of polyribosomes and inhibition of translation. Interestingly, they 
have found also that the poly(A) tail was longer in the cells lacking PABP. It was proposed that 
PABP was required for deadenylation (Sachs and Davis, 1989).  
 PABPs have been characterized in a number of protozoan species such as Leishmania 
major (Lm), Trypanosome brucei (Tb), and Plasmodium falciparum (Pf). Three distinct PABPs 
were studied in Lm named LmPABP1, LmPABP2, and LmPABP3 (Lima et al., 2010). It was 
demonstrated that these PABPs have divergent functions and the LmPABP1 and 2 are important 
for the cell viability (Lima et al., 2010). Under normal conditions, all three LmPABPs were 
distributed throughout the cytoplasm. Interestingly, when the cell underwent treatment by a 
transcription inhibitor (actinomycin D), LmPABP1 was localized mainly in the cytoplasm 
whereas the other two proteins were entirely migrated to the nucleus (Lima et al., 2010). Tb 
encodes two PABPs, TbPABP1 and TbPABP2. Kramer et al. (2013) found that TbPABP1 was 
varied in its localization from TbPABP2. Both were localized in the cytoplasm; however, when 
cells treated with Sinefungin (a chemical that functions to block the methylation of bases in 
DNA and RNA) and heat shock, only TbPABP2 migrated to the nucleus (Kramer et al., 2013). 
Both TbPABPs were found to interact with the translational machinery but with different 
transcripts (Kramer et al., 2013). Pf was indicated to encode two PABPs: MAL13P1.303 (414 
amino acids) and PFL1170w (875 amino acids) (PlasmoDB). Tuteja and Pradhan (2009) studied 
some proteins vital in the translation machinery, PfeIF4G, PfeIF4E, PfeIF4A (PfH45) and 
PfPABP (PFL1170w). They demonstrated that these factors are active translational components 
(Tuteja and Pradhan, 2009).     
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1.10 Research goals and hypothesis 
 
 Previous studies have shown that the accumulation and distribution of mRNPs are part 
of post-transcriptional gene regulation. PABP is an importantly conserved protein and 
involved in various critical steps of translation. I hypothesized that TgPABP is a vital 
molecules in the formation of mRNP granules to maintain homeostasis of gene expression 
during different conditions in T. gondii. Due to the native interaction of PABP and the 
poly(A) tract of mRNAs, TgPABP is considered an excellent diagnostic tool in monitoring of 
the location and the formation of mRNP complexes and granules. The objectives of the study 
are to gain a better understanding of an aspect of post-transcriptional regulation via the 
formation and accumulation of mRNP granules using fluorescence tagged version of 
TgPABP. The study was divided to different sections:       
1. To create a reliable and sensitive diagnostic tool used in monitoring mRNP 
granules, the single predicted TgPABP was tagged with fluorescence protein via a 
genetic approach called homologous recombination. The expression of fluorescence 
protein tagged TgPAPB is under the control of its own promoter and thus expressed 
at the level similar to that of its parental strain.  
2. To gain a better understanding of how the formation of mRNP granules be 
influenced by various growth conditions, transgenic parasites expressing 
fluorescence protein tagged TgPAPB were grown under following conditions:  
a) Normal growth conditions were used in order to establish the baseline(s) of the 
accumulation and distribution of TgPABP and corresponding mRNP granules in 
intracellular and extracellular tachyzoites. 
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b) Treatments with salubrinal and/or cycloheximide were used in order to simulate 
stressful conditions where translational processes were suppressed. 
c) Treatments with actinomycin D were used in order to simulate stressful 
conditions where transcription processes were suppressed. 
d) Nutrient limited growing conditions were used in order to simulate those of 
starvation which could cause growth adaptation. 
3. To gain a better understanding of the nature and composition of mRNP granules, a 
comparative analysis of the formation of mRNPs granules containing TgHoDI and 
those of PABP was conducted using parasites expressing either TgHoDI or PABP 
where they were subjected to similar treatment conditions.   
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CHAPTER II 
MATERIALS AND METHODS 
 
2.1 Cell culture 
2.1.1 Host cell cultures 
The intracellular T. gondii was propagated and maintained in Human Foreskin 
Fibroblasts (HFF, ATCC-1041). To provide nourishment, HFF cells were supplemented with 
Dulbecco’s Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine 
(Invitrogen, #12100046) and with 10% cosmic calf serum (ThermoFisher Scientific, Hylcone, # 
H3008704N), and 5μg/ml antibiotic antimitotic (Invitrogen, # 15240-062) at 37oC in 5% CO2. 
2.1.2 Toxoplasma gondii  
After confluence growth of HFF cells as a monolayer, it was infected with sufficient 
amount of T. gondii. MEM media were used for propagating tachyzoites growth, and it was 
supplemented with L-glutamine and 1% newborn fetal bovine serum (NFBS) (Hyclone) and 
0.5% antibiotic antimitotic (Invitrogen, # 15240-062).  
Confluent HFF cells, grown on coverslips, were infected with about 300 µL of freshly 
lysed tachyzoites and incubated at 37ºC hours in MEM media supplemented with L-glutamine 
and 1% newborn fetal bovine serum (NFBS) (Hyclone) and 0.5% antibiotic antimitotic 
(Invitrogen, # 15240-062). After 4 hours, MEM media was replaced with RPMI media 
(Invitrogen), pH 8.3, to induce the bradyzoite formation. RPMI media was changed every 24 
hours for 3 – 4 days.  
  
2.2 Plasmid Construction  
The following plasmid was constructed throughout the Ligation Independent Cloning 
(LIC) method: PABP-tdTomato-LIC-DHFR (the plasmid tdTomato-LIC-DHFR obtained from 
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Dr. Vernon B. Carruthers, Univ. of Michigan, U.S.A). Protocol for LIC cloning was performed 
as it was described previously in (Huynh et al., 2009). We used the type I strain of Toxoplasma 
gondii RHHX lacking the Ku80 gene to improve homologous recombination. Sequences for 
the gene PABP (TGGT1_ 224850) were obtained from the TOXODB.ORG website.  To amplify 
3ʹ end of the coding sequence (CDS) of PABP, we used LIC primers, shown in table 1. The LIC 
primers contain homologues at 3ʹ and 5ʹ end with LIC plasmid vectors; the map for the plasmid 
after cloning are indicated in Appendix A. This plasmid was used to tag PABP protein with td-
Tomato at the C-terminus, 1.1 kb from PABP was amplified. All parental vectors were linearized 
using the endonuclease enzyme pacI from NEB with overnight incubation. Both the PCR product 
of PABP and the cut plasmids followed with the T4 treatment using T4 DNA polymerase from 
NEB as it was described previously in (Huynh et al., 2009). After treatment, 2 μL of the insert 
and 1 μL of the vector were mixed at room temperature for 10 minutes followed with addition of 
1 μL of 25 mM EDTA and incubation for 5 minutes at room temperature. The 4 μL sample then 
transformed to 25 μL of competent cells and incubated overnight at 37oC. To confirm the 
desired clone, digestion analysis with endonucleases restriction enzymes EcoRI and XhoI for 
PABP.  
Table 2.1: list of Oligonucleotides used in this study: 
Oligonucleotide Name  Sequence 5’-3’  
FWLIC_tgPABP (A) TACTTCCAATCCAATTTAATgcgtcagctgttcgagccatt 
RVLIC_tgPABP (A’) TCCTCCACTTCCAATTTTAGCactcgcctgctgaagcaccct 
TgPABP Validate Fw (B) ACCACGACAGCGCGAAGG 
ptdTomato_Validate Rv (B’) ACCTCCTCGCCCTTGCTCTCAC 
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2.3 Polymerase Chain Reaction (PCR): 
PCR was performed according to the manufacturer’s manual (OneTaq® DNA 
Polymerase, NEB).  PCR was used to generate products to be used for cloning or for screening 
analysis. Reaction of 25 µL containing 200 µM dNTP, 0.2 µM primers, 0.125 µL, 1 µL template 
(1 µg), 5 µL of 5X OneTaq Standard, and volume of dH2O to 25 µL.  The PCR reaction was 
carried out in the 96-well BioRad T100TM Thermal Cycler, in 30 cycles (94ºC for 30 seconds, 
55ºC for 15 sec, 72ºC according the length of products, one minute per 1 kb). The PCR product 
was purified by Gel extraction technique (QIAEX®, Cat. No. 20021). 
 
2.4 Transformation of microorganisms 
2.4.1 Bacterial Transformation 
Protocol of bacterial transformation was performed as previously it was described in 
(Sambrook et al., 1989). 5 μL of Plasmid DNA was incubated with 25 μL of DH5α on ice for 30 
minutes. To allow the bacteria to take up the plasmid, mixture were then heat shocked at 42ºC 
for 45 seconds and incubated on ice for 2 minutes. Then, 500 µL of Super Optimal Broth with 
catabolite-repression (SOC Medium) (2% w/v bacto-tryptone, 0.5% w/v bacto-yeast extract, 
0.05% w/v NaCl, 10 mM MgCl2, 2.5 mM KCl and 20 mM glucose). was added to bacteria to 
allow resistant gene to be expressed and it is incubated 37ºC for 1 hour with agitation. About 100 
μL was streaked on an Luria Bertani (LB) (1% w/v bacto-tryptone, 0.5% w/v bacto-yeast, 1% 
w/v NaCl, 1 x 10-4 % w/v antibiotic and 1.5% w/v bacto-agar) agar plate with Ampicillin 
antibiotic and grown at 37ºC overnight. 
2.4.2 Toxoplasma gondii 
Protocol was performed as it was previously described in (Soldati & Boothroyd, 1993). 
Freshly lysed ∆Ku80 parasites were centrifuged at 5000 rpm for 5 minutes and the pellet was 
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resuspended with 400 μL Electroporation mixture buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM 
K2HPO4/KH2PO4 (pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione.), 2 mM 
ATP and 5 mM glutathione were added to the mixture prior to electroporation. 50 μg of 
linearized plasmid, PABP-tdTomato-LIC-DHFR was linearized with NsiI, was mixed with the 
mixture and transferred to 4 mm electroporation cuvettes. The instrument BTX ECM 630 
(Voltage: 1500, Resistance: 25 Ω, Capacitance: 25 μF).  Immediately after electroporation, the 
parasites were cultured in confluent HFF monolayers grown using MEM with 1% dFBS and 
antibiotic-antimycotic at 37ºC in 5% CO2. 24 hours post infection, media was replaced with 
MEM supplemented with 1% dFBS, 0.5x antibioticantimycotic, 1 μM pyrimethamine to select 
the transgenic parasites. 
 
2.5 Purification of a Single Transgenic Stable Clone 
The fluorescent protein was observed under the fluorescence microscopy in the second 
generation of intracellular transgenic parasite. Protocol to isolate a single stable transgenic 
parasite was performed as it was describe in (Rommereim et al., 2013). Freshly lysed parasites 
were counted using the haemocytometer chamber and dilution of 1 parasite per 200 µL was 
applied. Then, it was followed with infecting the HFF confluent cells in 96-well plates. 5 to 6 
days, the well contains a single Parasitophorous Vacuole was labelled and observed under the 
microscope for fluorescent protein. When the parasites lysed out, they were subcultured to 24-
well plates. The transgenic parasites then confirmed with PCR and western blotting analysis. 
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2.6 Protein Quantification:   
Freshly lysed parasites were pelleted through centrifugation at 5500 rpm for 5 minutes 
and resuspended in 50 µL of RIPA buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% w/v 
Triton X-100, 1% w/v sodium deoxycholate and 0.1% w/v SDS.) with PMSF and Pefabloc 
proteases inhibitor. Proteins were isolated by freezing and thawing samples for 10 minutes each. 
Protein concentration was measured using the RC DC Protein Assay according to manufacturer’s 
instructions (Bio-Rad Laboratories, Cat #500-0119). The samples diluted in RIPA buffer to the 
volume 500 µL and combined with Bradford reagent. Standard samples were prepared using the 
BSA with concentration ranging from 0 – 10 µg/mL. Absorbance was measured at 595 nm on 
the Genesys 10 UV/Visible spectrophotometer. A standard curve was constructed using 
Microsoft Excel to allow subsequent determination of the protein concentration in the tested 
samples. 
 
2.7 Western Blotting:  
Protocol was performed as it was previously described in (Sambrook et al., 1993). 50 µg 
of lysates were denatured using (12% w/v SDS, 0.06% w/v bromophenol blue, 47% v/v glycerol, 
6% v/v 1M Tris-pH 6.8 and 12.5% v/v β-mercaptoethanol.). This mixture then was heated for 10 
minutes to break the hydrogen bonds within the protein. Then, it was resolved on a 7% SDS-
PAGE for 1 hour. Following the transfer to the nitrocellulose membrane for 3 hours at 70 
voltage, blots were blocked in 5% (w/v) non-fat skim milk in TBST (68 mM NaCl, 8.3 mM Tris-
base (pH 7.6) and 0.05% v/v Tween-20) for 1 hour.  Then, it was following with primary 
antibodies with overnight incubation in 2% (w/v) non-fat skim milk in TBST. The following 
primary antibodies were used: rabbit Anti-RFP (1:5000), mouse anti-Tubulin (1:5,000), mouse 
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anti-FLAG (1:5,000). Then, blots were washed with TBST three times for 5 minutes each. The 
appropriate secondary antibodies were used conjugated with binding sites for Horseradish 
Peroxidase as following: HRP)-goat anti-mouse (1:10,000), HRP-rabbit anti-goat (1:10,000), 
HRP-goat anti-rabbit (1:20,000). Finally, blots were washed with TBST three times for 5 
minutes each, incubated with Chemiluminescent HRP Substrate Kit (Millipore) and visualized 
using the FluorChem Q Imager (Alpha Innotech) with AlphaView-FluorChem Q software. 
 
2.8 Drug and Starvation Treatments: 
Treatment of extracellular parasites, freshly lysed parasites were incubated on coverslips 
to allow to adhere for about 30 minutes. Parasites were then treated with: 5 µM salubrinal (SC-
202332, Lot # B1913) and/or 50 µg/mL cycloheximide (Sigma (C7698-1G)), or 0.05 µM 
actinomycin D. Following, IFA analysis was performed as it is explained in the next section. 
Treatment of intracellular parasites, 100 µL of freshly lysed parasites transferred to 70 – 
80 % confluent HFF grown on coverslips. After 24 hours, cells were treated with HBSS media, 5 
µM salubrinal, or 50 µg/mL cycloheximide for indicated times as shown in the result chapter. 
Following, IFA analysis was performed as it is described in the next section. 
 
 
2.9 Immunofluorescence Assay:  
Cells were rinsed three times with 1x (v/v) phosphate buffer saline (PBS), then the cells 
were fixed with 4% (w/v) paraformaldehyde for 10 minutes and permeabilized with 0.25% 
Triton X-100 in PBS for 10 minutes. Then, coverslips were washed in 1x PBS and subsequently 
incubated in a blocking solution of 5% (w/v) bovine serum albumin (BSA) in PBS with gentle 
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agitation for 1 hour at room temperature. Coverslips were then incubated for 1 hour in a 
humidity chamber with a specific primary antibody diluted in 2% (w/v) BSA. Cells were once 
again washed in 1x PBS. The secondary antibodies used were: Cells were then stained with 
Hoechst stain (100 μM) at room temperature, washed three times with 1x PBS and mounted on 
glass slides with fluoromount. Post-acquisition image processing was performed with Adobe 
Photoshop 7.0.  
For extracellular T. gondii, freshly lysed parasites were incubated on coverslips to allow 
them to adhere for 1 hour. Coverslips were rinsed in 1x (v/v) PBS and fixed with 4% (w/v) 
paraformaldehyde for 10 minutes. The remaining protocol was as previously described.  
2.10 Fluorescence Microscopy:  
 Fluorescence images were obtained using a Leica DMI 6000 fluorescence microscope, 
with a Leica DFC 360FX camera and a Leica STP6000 control board. Fields of fluorescent cells 
were located at the 40X objective and images were obtained under the 100X oil objective, NA 
1.4 oil; PL APO and a 1.52 refraction index. The blue filter was used in the detection of Hoechst 
33342 (ex. 350 nm, em. 461 nm), the green filter was used to detect AlexaFluor488 (ex. 495 nm, 
em. 519 nm), and the red filter was used to detect the Red Fluorescent Protein (ex. 554 nm, em. 
581nm). Multiple images were obtained per sample and the green, blue or red images were 
merged using the ImageJ software. 
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CHAPTER III 
RESULTS 
 
3.1 Toxoplasma gondii PABP (TgPABP) sequence analysis 
PABPs have been described to involve in several steps in gene expression and translational 
silencing in eukaryotes ranging from single cell organisms such as yeast and Toxoplasma to 
more complex organism such as human (Smith et al. 2014). According to the ToxoDB.org 
(version 13.0), only TGGT1_224850 is annotated as a gene coding for putative polyadenylate 
binding protein in Toxoplasma  type I. To identify important domains of PABP in the protein 
encoded by TGGT1_224850, the primary structures of PABPs from various organisms including 
Homo sapiens (Hs), Mus musculus (Mm), trypanosoma brucei (Tb), Plasmodium falciparum 
(Pf), and Saccharomyces cerevisiae (Sc) were aligned to that of TgPABP using ClustalW. Five 
conserved domains were identified as shown in Figure 3.1. All PABP homologs have four RRMs 
and C-terminal domain (PABC). Utilizing the LALIGN software from the ExPASy website, the 
percentage of similarities to TgPABP is as follow: Hs: 64.9, Mm: 64.9, Tb1: 63.7, Tb2: 56.5, Pf: 
61.1, and Sc: 71.9. These alignments display that the RRMs domains are conserve among 
eukaryotes. Due to the high similarities between TgPABP to PABPC1, which is the most 
characterized protein among these eukaryotes, further analysis was performed for each single 
RRM. RRM1, 2 and 4 in TgPABP are 70% similar to PABPC1 whereas RRM3 and PAPBC are 
43 and 66, respectively. Notably, few amino acids separate between the first four domains 
RRM1 – RRM4 at N-terminus whereas larger gap between RRM4 and the PABC domain. Also, 
the length of amino acids are between 550 – 650 for Hs, Mm, and Tb, while Pf and Tg are larger 
by more than 100 amino acids.      
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PABPC1_Hs       ------------------------------------------------------------ 
PABP_mm         ------------------------------------------------------------ 
PABP_Sc         -----------MADITDKTAEQLENLNIQDDQKQAAT----------------------- 26 
PABP_Pf         -------------------------------MIATGT----------------------- 6 
PABP_Tg         MATASPVVAPSSPASAPSQPSPMPASNAGADVPASGTGGHQAAADHTAGNANVSGGVSGT 60 
PABP1_Tb        -------------------------MTIAAQGVPSGP----------------------- 12 
PABP2_Tb        ------------------------------------------------------------ 
                                                                             
 
PABPC1_Hs       ------------MNPSAPSYPMASLYVGDLHPDVTEAMLYEKFSPAGPILSIRVCRDMIT 48 
PABP_mm         ------------MNPSAPSYPMASLYVGDLHPDVTEAMLYEKFSPAGPILSIRVCRDMIT 48 
PABP_Sc         -----------GSESQSVENSSASLYVGDLEPSVSEAHLYDIFSPIGSVSSIRVCRDAIT 75 
PABP_Pf         -------------NMMHPSFSTASLYVGDLNEDVTEAVLYEIFNTVGHVSSIRVCRDSVT 53 
PABP_Tg         TPAPAGQRPNGGMNAGAANFVSPSLYVGDLHQDVTEAMLFEVFNSVGPVTSIRVCRDTVT 120 
PABP1_Tb        --------------SATKPLQVASLYVGDLDPAINEPQLVDIFKPYGTILNVRVCRDIIT 58 
PABP2_Tb        --------------MAAFAAASPSIWVGGLDPNLNEQKLYDHFVRVGPVASVRVCVDSVT 46 
                                      .*::**.*.  :.*  * : *   * : .:*** * :* 
 
PABPC1_Hs       RRSLGYAYVNFQQPADAERALDTMNFDVIKGKPVRIMWSQRDPSLRKSGVGNIFIKNLDK 108 
PABP_mm         RRSLGYAYVNFQQPADAERALDTMNFDVIKGKPVRIMWSQRDPSLRKSGVGNIFIKNLDK 108 
PABP_Sc         KTSLGYAYVNFNDHEAGRKAIEQLNYTPIKGRLCRIMWSQRDPSLRKKGSGNIFIKNLHP 135 
PABP_Pf         RKSLGYAYVNYHNLADAERALDTLNYTNIKGQPARLMWSHRDPSLRKSGTGNIFVKNLDK 113 
PABP_Tg         RRSLGYAYVNYQGIQDAERSLDTLNYTVIKGQPCRIMWCHRDPSLRKSGNGNIFVKNLDK 180 
PABP1_Tb        QRSLGYGYVNYDDVNSASKAMEELNFKRVGEKCIRIMWQQRDPALRYSGSGNIFVKNLKE 118 
PABP2_Tb        QKSLGYGYVNFQNPADAEKALDQAG-VKLGTKHIRIAKIQRDPSKRRSGVTNIIVKKLPP 105 
                : ****.***:.    . ::::  .   :  :  *:   :***: * .*  **::*:*   
 
PABPC1_Hs       SIDNKALYDTFSAFGNILSCKVVCDENG-SKGYGFVHFETQEAAERAIEKMNG----MLL 163 
PABP_mm         SIDNKALYDTFSAFGNILSCKVVCDENG-SKGYGFVHFETQEAAERAIEKMNG----MLL 163 
PABP_Sc         DIDNKALYDTFSVFGDILSSKIATDENGKSKGFGFVHFEEEGAAKEAIDALNG----MLL 191 
PABP_Pf         SIDNKALFDTFSMFGNILSCKVATDEFGKSKSYGFVHYEDEESAKEAIEKVNG----VQL 169 
PABP_Tg         NIDNKALYDTFSLFGNILSCKVAVDDNGHSKGYGFVHYENEESARSAIDKVNG----MLI 236 
PABP1_Tb        EVDSRELSLIFKKFGEILSCKVMDDESGKSRGYGFVHFKDDDAAKAAIEKMNGDKEHADA 178 
PABP2_Tb        TVDTYALKEMFSKYGRLTAIGLATDEKGESRGYARISYEKEESAVDAVRELNG----VSI 161 
                 :*.  *   *. :* : :  :  *: * *:.:. : :: : :*  *:  :**        
 
PABPC1_Hs       NDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGEDMD-DERLKDLFGKFGPALSVKV 222 
PABP_mm         NDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGEDMD-DERLKELFGKFGPALSVKV 222 
PABP_Sc         NGQEIYVAPHLSRKERDSQLEETKAHYTNLYVKNINSETT-DEQFQELFAKFGPIVSASL 250 
PABP_Pf         GSKNVYVGPFIKKSER----ATNDTKFTNLYVKNFPDSVT-ETHLRQLFNPYGEITSMIV 224 
PABP_Tg         GGKTVYVGPFIRRAERD---NLAEAKYTNVYIKNMPSAWEDESRLRETFSKFGSITSLVV 293 
PABP1_Tb        DKAALYVANFIRRNAR---LAALVANFTNVYIKQLLPTVD-KDVIEKFFSKFGGITSAAI 234 
PABP2_Tb        DDCAITVERYQPHHREE-----QLKQYTNLYVKNLDPSVD-DEKLKEVFSPFGEVTSAKV 215 
                .   : *  .  :  .         .:**:*:*::      .  :.. *  :*   *  : 
 
PABPC1_Hs       MTDESGKSKGFGFVSFERHEDAQKAVDEMNGKELNGKQ---------------------- 260 
PABP_mm         MTDESGKSKGFGFVSFERHEDAQKAVDEMNGKELNGKQ---------------------- 260 
PABP_Sc         EKDADGKLKGFGFVNYEKHEDAVKAVEALNDSELNGEK---------------------- 288 
PABP_Pf         KMDNKNRK--FCFINYADAESAKNAMDNLNGKKITDDGQIDETYDPKKEEATASTSGAAN 282 
PABP_Tg         RKDPKGRL--FAFCNFADHDSAKAAVEALNGKRVTDAGAIKEGED--------------- 336 
PABP1_Tb        CKDKNGRA--FAFCNFEKHDDAVKAIEASHDQEVEGVTQPGEK----------------- 275 
PABP2_Tb        RDLAGRPTVGFGYVAYATHEAAAKAVEELDDKESPLAKEG-------------------- 255 
                          * :  :   : *  *::  ....                            
PABPC1_Hs       ------------------------------------------------------------ 
PABP_mm         ------------------------------------------------------------ 
PABP_Sc         ------------------------------------------------------------ 
PABP_Pf         QTTGTDADKTDKNDKNNKADKNEKGDSSNANNNATATGATTTDTTTTPGETTTTTANADS 342 
PABP_Tg         --SGAEEEKEEEGQKR-------EGD---------------------------------- 353 
PABP1_Tb        ------------------------------------------------------------ 
PABP2_Tb        ------------------------------------------------------------ 
RRM1 
RRM2 
RRM3 
RRM1 RRM2 RRM3 RRM4 PABC 
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PABPC1_Hs       ------------------------------------------------------------ 
PABP_mm         ------------------------------------------------------------ 
PABP_Sc         ------------------------------------------------------------ 
PABP_Pf         TGANNNNGLSPNTNTSNTTTGSSNNSINLNENNNTAGNNNSTNNNNNSGSSMNNAGSAKK 402 
PABP_Tg         ------------------------------------------------------------ 
PABP1_Tb        ------------------------------------------------------------ 
PABP2_Tb        ------------------------------------------------------------ 
                                                                             
 
PABPC1_Hs       --------------IYVGRAQKKVERQTELKRKFEQMKQDRITRYQGVNLYVKNLDDGID 306 
PABP_mm         --------------IYVGRAQKKVERQTELKRKFEQMKQDRITRYQGVNLYVKNLDDGID 306 
PABP_Sc         --------------LYVGRAQKKNERMHVLKKQYEAYRLEKMAKYQGVNLFVKNLDDSVD 334 
PABP_Pf         DETAASDCADTPNILYVGPHQSRARRHAILKAKFDNLNVENKNKHQGVNLYIKNLDDGID 462 
PABP_Tg         ------------QILFVGPHQSKAHRSAMLRAKFEQMNQDRNDRFQGVNLYIKNMDDSID 401 
PABP1_Tb        --------------LYVQRAQPRSERLIALRQKYMQCQS------LGNNLYVRNFDAEFT 315 
PABP2_Tb        ------------MKLSVCRFRSREERKRERERLRRERQQQ---HSKYPNLYVKNFDDTVT 300 
                              : *   : : .*    .      .          **:::*:*  .  
 
PABPC1_Hs       DERLRKEFSPFGTITSAKVM-MEGGRS-KGFGFVCFSSPEEATKAVTEMNGRIVAT-KPL 363 
PABP_mm         DERLRKEFSPFGTITSAKVM-MEGGRS-KGFGFVCFSSPEEATKAVTEMNGRIVAT-KPL 363 
PABP_Sc         DEKLEEEFAPYGTITSAKVMRTENGKS-KGFGFVCFSTPEEATKAITEKNQQIVAG-KPL 392 
PABP_Pf         DIMLRELFEPFGTITSAKVMRDEKEQS-KGFGFVCFASQEEANKAVTEMHLKIING-KPL 520 
PABP_Tg         DEKLRQLFEPFGSITSAKVMRDERGVS-RCFGFVCFMSPEEATKAVTEMHLKLVKG-KPL 459 
PABP1_Tb        EKDLNELFKEYGVIRSCRVMTDANGIS-RGFGFVSFENADQANAALREMNGRMLNG-KPL 373 
PABP2_Tb        SERLKALFDPFGETVSVSVMMDKATKVSRCFGFVSFKEQSSAAQAIQELHGSTALGPRPL 360 
                .  *.  *  :*   *  **        : ****.*   ..*  *: * :       :** 
 
PABPC1_Hs       YVALAQRKEERQAHLTNQYMQRMASVRAVPNPVINPYQPAPPSG---------------- 407 
PABP_mm         YVALAQRKEERQAHLTNQYMQRMASVRAVPNPVINPYQPAPPSG---------------- 407 
PABP_Sc         YVAIAQRKDVRRSQLAQQIQARNQMR----------YQQATAA----------------- 425 
PABP_Pf         YVGLAEKREQRLSRLQQRFRMHPIRHHMNNPLNTPMQYASPQSPQLQFSQNTLSYGRPVI 580 
PABP_Tg         YVGLAERREQRLMRLQQRFRLPSLRPAAAALPGN--VAAAAAAAQLQYGG-----GAPQL 512 
PABP1_Tb        VVNIAQRRDQRLTMLKLQLQQRLQMMMHHMHPPPFGMPGHPLQR---------------- 417 
PABP2_Tb        FVSYALRKDARRQTLEDMRNKQPRMRQPPMGGLMGGMMGPQLSFMN-------------- 406 
                 *  * ::: *   *                                              
 
PABPC1_Hs       -----------YFMAAIPQTQNRAAYYPPSQIAQLRPSPRWTAQGARPHPFQNM------ 450 
PABP_mm         -----------YFMAAIPQTQNRAAYYPPSQIAQLRPSPRWTAQGARPHPFQNM------ 450 
PABP_Sc         --------------AAAAAAGMPGQFMPPMFYGVMPP---------RGVPFN-------- 454 
PABP_Pf         TAFNQNNLISWRHQQAAQQQAVHQQAVHQQAAQQQLNFNTNLRGQINQMRLYTQNNMMNN 640 
PABP_Tg         QGFAAG-----PGAMYAPRPLMGFSPHPHQVTAPMLPWRQ-QQAAAAGAQFASQGVPMRP 566 
PABP1_Tb        --------------RNARSGGRGNRPHPRQQQPQPQP----------------------- 440 
PABP2_Tb        --------------PPAMFNGMHFMNTRMPMMPSTMG----------------------- 429 
                                                                             
PABPC1_Hs       ------PGAIRPAAPRPPFSTMRPASSQVPRVMSTQRVANTSTQTMGPR----------- 493 
PABP_mm         ------PGAIRPAAPRPPFSTMRPASSQVPRVMSTQRVANTSTQTMGPR----------- 493 
PABP_Sc         -------------GPNP--------------------------QQMNPM----------- 464 
PABP_Pf         NLNQNKPNAQLHHNQQYVPNALAQNGQQQPNLNAAGQHNAQQLQQQGNNQLLNNNMRNMN 700 
PABP_Tg         QLG---PLQHLYGQTNAAAAAVAAG----MHAAAAGGPPMQMLQQQQRG----------- 608 
PABP1_Tb        -------------EPQPPLATTVPP------------AAAHSVMFTAPS----------- 464 
PABP2_Tb        -----------MGGPMRPMGPTPMN---------------QVRARPGPQ----------- 452 
                                                                             
 
PABPC1_Hs       --------------------------------------------PAAAAAAATPAVRTVP 509 
PABP_mm         --------------------------------------------PAAAAAAATPAVRTVP 509 
PABP_Sc         --------------------------------------------GGMPKNGMPPQFRNGP 480 
PABP_Pf         NRANRNMGNLGNMNNQKQLPLNINNKQQNAASQANQMNHQAQPQGAQAQQKNPQQMQQVP 760 
PABP_Tg         -------GHRGGMGRQGGAGPVLNGNKQ-------HMIGPKPGAGQQQPQGGPGSFKFTP 654 
PABP1_Tb        ----------------------------------------------MGFSAVPRTPQASP 478 
PABP2_Tb        --------------------------------------------RPPMQSMMAPQQQSHP 468 
                                                                    .   :  * 
 
 
RRM4 
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PABPC1_Hs       QYKYAAGVRNPQQHLNAQPQ------VTMQQPAVHVQGQEPLTASMLASAPPQEQKQMLG 563 
PABP_mm         QYKYAAGVRNPQQHLNAQPQ------VTMQQPAVHVQGQEPLTASMLASAPPQEQKQMLG 563 
PABP_Sc         VYG------------------------------VPPQGGFPRNANDNNQFYQQKQRQALG 510 
PABP_Pf         QGNNFKFTAQARNRMELPNKNANKVNTMNNNMNVNFNNNSTLTAAALASAPPSMQKQVLG 820 
PABP_Tg         QVRNQRLDQQMQPPASVPAPHNHHQVMMEQSQQLLMNPDAPLTAAALAAAQPSMQKQMLG 714 
PABP1_Tb        AIAP------------------------------DTPPLPPISAEDLQQMSVDEQRAALG 508 
PABP2_Tb        QIPQ------------------------------PPVAQGQNLSTVLASMTPDQQKNVLG 498 
                                                           :        . *:  ** 
 
PABPC1_Hs       ERLFPLIQAMHPT--LAGKITGMLLEIDNSELLHMLESPESLRSKVDEAVAVLQAHQAKE 621 
PABP_mm         ERLFPLIQAMHPS--LAGKITGMLLEIDNSELLHMLESPESLRSKVDEAVAVLQAHQAKE 621 
PABP_Sc         EQLYKKVSAKTSNEEAAGKITGMILDLPPQEVFPLLESDELFEQHYKEASAAYESFK-KE 569 
PABP_Pf         ENLFPLVANYHPT--LAGKITGMMLEMDNSELLILLENEEQLKKKIDEALVVLQKAK--- 875 
PABP_Tg         EKLFPLIARYQPE--LAGKITGMMLEMDNAELLILLESEAQLKAKVDEALRVLQQAS--- 769 
PABP1_Tb        DRLYIKVHELAPD--HAPKITGMFLEMNPKEALALLSNPKLMHEKVTEALCVLKVHASSA 566 
PABP2_Tb        ERLYNYIVRNNPS--FAAKVTGMLLEMDNSEILNLLDNHSLLDTKVQEALDVLNRHIGM- 555 
                :.*:  :    .    * *:***:*::   * : :*..   :  :  **  . :       
 
PABPC1_Hs       AAQKAVNSATGVPTV 636 
PABP_mm         AAQKAVNSATGVPTV 636 
PABP_Sc         QEQQTEQA------- 577 
PABP_Pf         --------------- 
PABP_Tg         --------------- 
PABP1_Tb        --------------- 
PABP2_Tb        --------------- 
 
Figure 3.1: Alignment of TgPABP of Toxoplasma with other PABPs from other eukaryotes  
The alignment for PABP cytoplasmic 1 from Hs (PABPC1_Hs accession number: P11940), Mm 
(PABP_mm accession number: P29341), Sc (PABP_Sc accession number: A0A023ZCC3), Pf 
(PABP_Pf accession number: PF3D7_1224300), Tg (PABP_Tg accession number: 
TGGT1_224850), and Tb (PABP1_Tb and PABP2_Tb accession numbers: Tb09.211.0930 and 
Tb09.211.2150, respectively).  
 
 
 
 
 
 
 
 
 
PABC 
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Since TgPAPB exhibits a high amino acid identity to human PABPC1 (Figure 3.1), it was 
expected that commercially available polyclonal antibodies raised against human PABP 
cytoplasmic homologs would react with TgPABP. Immuno-blot analysis was performed using 
cell-free lysates of Toxoplasma. Multiple bands were revealed (Figure 3.2), suggesting that 
multiple proteins carry immunogenic epitopes similar to those of antigen of human PABP. The 
predicted amino acid sequence (769 aa) of TgPABP with a molecular mass of 82,699 Da. The 
band resolved at ~80 kDa was indicated by asterisk (Figure 3.2). This result showed that antisera 
against human PABP is not suitable to use for TgPABP detection.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Western blot for HFF and Toxoplasma lysates. 
 
Lysates prepared from Toxoplasma were run on SDS-PAGE and probed with ∞-PABP antibody 
(catY058722, ABM Inc). Toxoplasma lysates demonstrate multiple bands. The proteins sizes are 
indicated. 
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When the coding sequence (CDS) for TgPABP in type I strain was analysed in 
comparison to those of type II and III strains, it was found that TgPABP CDS of types I and III 
consist of 2310 nucleotides and that of type II is 2307 nucleotides. The gene is located on 
chromosome X. The gene coding for TgPABP in type II is longer than those of type I and III, 
with the presence of an intron of 3171 nucleotides. The amino acid sequence alignment of 
TgPABPs from the three archetypes displays high similarities (Figure 3.3). TgPABP (769 amino 
acids) of type I and III are 100% similarity in length of with a calculated molecular mass of 82.7 
kDa, and an isoelectric point of 9.15. TgPABP of type II has one amino acid less than those of 
types I and III, which reflects by the missing of Glutamine at position 341 (indicated by blue 
highlight, Figure 3.3). As a result, the molecular mass of TgPABP of type II is slightly lower, 
and its isoelectric point is 9.27. Slight difference was detected in the TgPABP from three 
archetypes, residue 62 of TgPABP of types I and III is Proline, and TgPABP of type II 
Threonine (indicated by green highlight, Figure 3.3). At physiological condition, 80 positively 
charged residues (Arg + Lys) and 71 negatively charged residues (Asp + Glu) were detected by 
using the ProtParam program. One possibility for higher number of positive residues is that to 
increase the efficiency of binding to the transcripts which are negatively charged molecules.  
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Type-I          MATASPVVAPSSPASAPSQPSPMPASNAGADVPASGTGGHQAAADHTAGNANVSGGVSGT 60 
Type-II         MATASPVVAPSSPASAPSQPSPMPASNAGADVPASGTGGHQAAADHTAGNANVSGGVSGT 60 
Type-III        MATASPVVAPSSPASAPSQPSPMPASNAGADVPASGTGGHQAAADHTAGNANVSGGVSGT 60 
                ************************************************************ 
Type-I          TPAPAGQRPNGGMNAGAANFVSPSLYVGDLHQDVTEAMLFEVFNSVGPVTSIRVCRDTVT 120 
Type-II         TTAPAGQRPNGGMNAGAANFVSPSLYVGDLHQDVTEAMLFEVFNSVGPVTSIRVCRDTVT 120 
Type-III        TPAPAGQRPNGGMNAGAANFVSPSLYVGDLHQDVTEAMLFEVFNSVGPVTSIRVCRDTVT 120 
                *.********************************************************** 
Type-I          RRSLGYAYVNYQGIQDAERSLDTLNYTVIKGQPCRIMWCHRDPSLRKSGNGNIFVKNLDK 180 
Type-II         RRSLGYAYVNYQGIQDAERSLDTLNYTVIKGQPCRIMWCHRDPSLRKSGNGNIFVKNLDK 180 
Type-III        RRSLGYAYVNYQGIQDAERSLDTLNYTVIKGQPCRIMWCHRDPSLRKSGNGNIFVKNLDK 180 
                ************************************************************ 
Type-I          NIDNKALYDTFSLFGNILSCKVAVDDNGHSKGYGFVHYENEESARSAIDKVNGMLIGGKT 240 
Type-II         NIDNKALYDTFSLFGNILSCKVAVDDNGHSKGYGFVHYENEESARSAIDKVNGMLIGGKT 240 
Type-III        NIDNKALYDTFSLFGNILSCKVAVDDNGHSKGYGFVHYENEESARSAIDKVNGMLIGGKT 240 
                ************************************************************ 
Type-I          VYVGPFIRRAERDNLAEAKYTNVYIKNMPSAWEDESRLRETFSKFGSITSLVVRKDPKGR 300 
Type-II         VYVGPFIRRAERDNLAEAKYTNVYIKNMPSAWEDESRLRETFSKFGSITSLVVRKDPKGR 300 
Type-III        VYVGPFIRRAERDNLAEAKYTNVYIKNMPSAWEDESRLRETFSKFGSITSLVVRKDPKGR 300 
                ************************************************************ 
Type-I          LFAFCNFADHDSAKAAVEALNGKRVTDAGAIKEGEDSGAEEEKEEEGQKREGDQILFVGP 360 
Type-II         LFAFCNFADHDSAKAAVEALNGKRVTDAGAIKEGEDSGAEE-KEEEGQKREGDQILFVGP 360 
Type-III        LFAFCNFADHDSAKAAVEALNGKRVTDAGAIKEGEDSGAEEEKEEEGQKREGDQILFVGP 359 
                ***************************************** ****************** 
Type-I          HQSKAHRSAMLRAKFEQMNQDRNDRFQGVNLYIKNMDDSIDDEKLRQLFEPFGSITSAKV 420 
Type-II         HQSKAHRSAMLRAKFEQMNQDRNDRFQGVNLYIKNMDDSIDDEKLRQLFEPFGSITSAKV 420 
Type-III        HQSKAHRSAMLRAKFEQMNQDRNDRFQGVNLYIKNMDDSIDDEKLRQLFEPFGSITSAKV 419 
                ************************************************************ 
Type-I          MRDERGVSRCFGFVCFMSPEEATKAVTEMHLKLVKGKPLYVGLAERREQRLMRLQQRFRL 480 
Type-II         MRDERGVSRCFGFVCFMSPEEATKAVTEMHLKLVKGKPLYVGLAERREQRLMRLQQRFRL 480 
Type-III        MRDERGVSRCFGFVCFMSPEEATKAVTEMHLKLVKGKPLYVGLAERREQRLMRLQQRFRL 479 
                ************************************************************ 
Type-I          PSLRPAAAALPGNVAAAAAAAQLQYGGGAPQLQGFAAGPGAMYAPRPLMGFSPHPHQVTA 540 
Type-II         PSLRPAAAALPGNVAAAAAAAQLQYGGGAPQLQGFAAGPGAMYAPRPLMGFSPHPHQVTA 540 
Type-III        PSLRPAAAALPGNVAAAAAAAQLQYGGGAPQLQGFAAGPGAMYAPRPLMGFSPHPHQVTA 539 
                ************************************************************ 
Type-I          PMLPWRQQQAAAAGAQFASQGVPMRPQLGPLQHLYGQTNAAAAAVAAGMHAAAAGGPPMQ 600 
Type-II         PMLPWRQQQAAAAGAQFASQGVPMRPQLGPLQHLYGQTNAAAAAVAAGMHAAAAGGPPMQ 600 
Type-III        PMLPWRQQQAAAAGAQFASQGVPMRPQLGPLQHLYGQTNAAAAAVAAGMHAAAAGGPPMQ 599 
                ************************************************************ 
Type-I          MLQQQQRGGHRGGMGRQGGAGPVLNGNKQHMIGPKPGAGQQQPQGGPGSFKFTPQVRNQR 660 
Type-II         MLQQQQRGGHRGGMGRQGGAGPVLNGNKQHMIGPKPGAGQQQPQGGPGSFKFTPQVRNQR 660 
Type-III        MLQQQQRGGHRGGMGRQGGAGPVLNGNKQHMIGPKPGAGQQQPQGGPGSFKFTPQVRNQR 659 
                ************************************************************ 
Type-I          LDQQMQPPASVPAPHNHHQVMMEQSQQLLMNPDAPLTAAALAAAQPSMQKQMLGEKLFPL 720 
Type-II         LDQQMQPPASVPAPHNHHQVMMEQSQQLLMNPDAPLTAAALAAAQPSMQKQMLGEKLFPL 720 
Type-III        LDQQMQPPASVPAPHNHHQVMMEQSQQLLMNPDAPLTAAALAAAQPSMQKQMLGEKLFPL 719 
                ************************************************************ 
Type-I          IARYQPELAGKITGMMLEMDNAELLILLESEAQLKAKVDEALRVLQQAS 769 
Type-II         IARYQPELAGKITGMMLEMDNAELLILLESEAQLKAKVDEALRVLQQAS 769 
Type-III        IARYQPELAGKITGMMLEMDNAELLILLESEAQLKAKVDEALRVLQQAS 768 
                ************************************************* 
Figure 3.3. The alignment of three TgPABPs for the three strains of Toxoplasma gondii  
ClustalW tool. An asterisk (*) indicates a fully conserved residue, while (.) signifies a 
weakly conserved residue. Type I and III strains shows 100% similarities and type II varies 
at residue 62 and 341 which are indicated.  
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Table 3.1 Bioinformatics analysis of TgPABP among the three archetypic strains of 
Toxoplasma gondii  
    
 
 
 Clonal Strain 
Type I (RH)  Type II (ME49)  Type III (VEG)  
 ToxoDB Gene ID  TGGT1_224850 TGME49_224850 TGVEG_224850 
 Chromosomal location  
2,687,512 - 2,689,821 
Chromosome: X 
2,771,800 - 2,780,642 
Chromosome: X 
2,677,455 - 2,679,764 
Chromosome: X 
 Genomic Sequence Length (bp) 2310 5478 2310 
 Coding Sequence Length  2310 2307 2310 
Number of Exons and Introns 
Introns: 0 
Exons: 1 
Introns: 1 
Exons: 1 
Introns: 0 
Exons: 1 
 Amino Acid Composition (aa) 769 768 769 
Molecular Weight  82699 Da 82574 Da 82699 Da 
Isoelectric Point  9.15 9.27 9.15 
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3.2 Generation of PABP-tdTomFP-tagged clonal parasite 
 To create a reliable and sensitive diagnostic tool used in monitoring mRNP granules, 
the single predicted TgPABP was tagged with fluorescence protein via a genetic approach called 
homologous recombination. Using a ligation independent cloning procedure describe by Huynh 
and Carruthers  (2009), the coding sequence of tdTomFP (1431 bp) was inserted in an in-frame 
format at the 3ʹ end right before the last triplet codon of TgPABP CDS. The transgenic clonal 
parasite expressing TgPABP-TomFP was confirmed through various methodologies. First, 
fluorescent microscopy was used in screening for the fluorescence signal of TgPABP-tdTomFP 
and selecting of clonal transgenic parasites. Secondly, to verify that the insertion of the tdTomFP 
transgene was integrated into the desired TgPABP locus, two sets of primers were designed for 
the study (Table 2.1). As shown in Figure 3.4, primers A and Aʹ were used to verify the 
successful PCR reactions of both the parental and the transgenic DNA samples, as these primers 
were able to anneal to specific sites of TgPABP to give 1.1 kb-products, whereas primers B and 
Bʹ were used to verify the presence of the tdTomFP transgene in the isolated genomic DNA 
samples (Figure 3.4 A). Amplicons of 1.1 kb were detected in both parental and transgenic 
strains, corresponding to the presence of TgPABP-CDS. No band of the transgene was detected 
in the parental strain, but one band with expected size of 1.5 kb in the transgenic strain was 
detected (Figure 3.4 B). Thirdly, to prove that the fusion of TgPABP-tdTomFP was produced in 
the transgenic clonal line, a western blot analysis was performed using α-RFP. A resolved band 
at ̴ 137 kDa, corresponding to TgPABP (82 kDa) fused to tdTomFP (54 kDa), was detected 
(Figure 3.4 C). For the loading control, α- tubulin was used, a band at  ̴ 53 kDa was revealed 
from both samples.  
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Figure 3.4: Analysis of transgenic parasites expressing the recombinant protein 
TgPABP-tdTomFP. (A) Illustration of parental and transgenic genomic arrangement with 
approximate location of annealing site designed PCR primers. Samples from parental ΔKu80 
parasites and chosen clonal transgenic parasites were analyzed genetically modified to have 
the fluorescent protein tdTomFP tagged with PABP (TGGT1_224850) at the C-terminus.  
(B) Agarose gel for PCR analysis to confirm that tdTomato-CDS was integrated at the end of 
TgPABP-CDS. (C) Western blotting analysis confirmed the presence TgPABP-tdTomFP 
fusion protein (at ~137 kDa). 
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3.3 Visualization of TgPABP localization via the fluorescence signal of tdTomFP-tag 
This experiment was performed to monitor the TgPABP localization within the 
parasites. Immune-fluorescence assays (IFA) were performed using the transgenic clone 
expressing TgPABP-tdTomFP to visualize TgPABP, and mRNAs in T. gondii under 
different culturing conditions. Under normal culturing conditions, TgPABP-tdTomFP was 
detected to distribute throughout the cytoplasm in the intracellular tachyzoites (Figure 3.5 A). 
Interestingly, we observed TgPABP was localized more at the basal end of the parasite (the 
basal end is shown by an arrow head, Figure 3.5, upper panel). No significance increase was 
noticed in the basal end of the parasite (Figure 3.5 B). When the parasites were culture under 
alkali condition, the intracellular tachyzoites were converted to bradyzoites, as demonstrated 
by the presence of cyst cell wall stained by fluorescein isothiocyanate (FITC)-conjugated 
Dolichos biflorus lectin, as a marker for bradyzoites conversion. Under the bradyzoite 
culturing conditions, TgPABP also distributed mainly in cytosol similar to intracellular 
tachyzoites (lower panel). 
Once egress, freely floating tachyzoites were collected and fixed on coverslips 
following with IFA. Freshly released tachyzoites, TgPABP accumulated in granules with 
higher aggregates at the basal end under their extracellular stage (arrow head, middle panel). 
The localization and distribution of TgPABP was identified by tdTomFP signal. TgPABP 
was more prominent as aggregates or granular structures in the extracellular parasites. The 
observed pattern of TgPABP accumulation were in agreement with those of mRNPs called 
stress granules as previous shown by Lirussi and Matrajt (2011). 
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A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: TgPABP localization 
(A) Parasites were stained with Hoechst (blue) to label the nucleus. Images were acquired using 
a 100x oil objective. Scale bars represent 5 µm. (B) Quantification of Fluorescence signals 
detected in intracellular tachyzoites. The signals were acquired from randomly chosen 50 
parasites using the ImageJ software. Excel 2013 were used to analyse data and obtained the error 
bars.     
 
Fl
u
o
re
sc
en
ce
 
(A
U
)
Intracellular tachyzoites
Basal end Apical end
0
100
200
300
400
500
600
49 
 
3.4 Distribution of TgPABP and mRNP granules under various treatment conditions  
Detection of the accumulation and distribution of mRNAs and their interacting proteins 
are important to understand the molecular mechanisms of gene regulation. Agents and conditions 
known to influence translation and transcription were utilized for the investigation for the 
distribution of TgPABP and consequently their mRNP granules.  
3.4.1 Effect of salubrinal 
Salubrinal inhibits translation at the initiation process through the inhibition of the eIF2α-P 
dephosphorylation and as a result prevents protein synthesis. The consequences of 
phosphorylation of eIF2α are not only reducing global protein synthesis but also altering the 
pattern of gene expression (Konrad et al., 2013). To determine the effects of protein synthesis 
inhibition by salubrinal, PABP-tdTomFP was tracked to monitor for polyadenylated mRNAs. 
Extracellular tachyzoites were collected immediately upon lysing host cells and then treated for 
one hour with 5 µM salubrinal. Granular structures were subsequently observed in the cytosol 
(Figure 3.6, upper panel). Granules between 0.1 – 0.4 µm were counted in 50 parasites with no 
treatment and after one hour treatment with Salubrinal (Figure 3.7). Extracellular tachyzoites had 
7 ± 1.93 granules whereas upon treatment of salubrinal it had 6 ± 2.14. This finding suggests that 
when the parasites are extracellular, salubrinal has no effects on mRNPs granules. This result 
also coincides with a previous study that showed TgHoDI, a marker for mRNPs stress granules, 
accumulates in larger number and size of granules when treated with salubrinal (Cherry and 
Ananvoranich, 2014). 
Similar concentration of salubrinal was applied on the intracellular parasites.   
Interestingly, after two hours of incubation, TgPABP containing granular structures were 
observed in the cytosol (Figure 3.6, middle panels). As the incubation extended for four hours, 
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seemingly more mRNPs were observed (lower panel). These granules were counted and their 
sized were measured for 50 parasites using the ImageJ software (Figure 3.7 A). The sizes of 
counted granules were in the range from 0.1 to 0.6 µm. For total number of granules, average of 
2.66 ± 0.71 granules were found after two hours incubation in 5 µM salubrinal and slight 
increase in number of granules 3.03 ± 0.89 after four hours. Also, three sets of granules were 
counted according to sizes (Figure 3.7 B). Most of granules were between 0.2- < 0.4 µm in all 
conditions. However, larger granules (0.4-0.6) were more noticeable after 4 hours treatment 
(Figure 3.7 B). To the best of my knowledge, this is the first experiment that shows TgPABP can 
be aggregated in granules, which is believed to be mRNPs, in the intracellular parasites when 
treated with salubrinal.  
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Figure 3.6: Effects of Salubrinal  
Parasites were fixed stained with Hoechst (blue) to label the nucleus. Images were acquired 
using a 100x oil objective. Scale bars represent 5 µm. 
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Figure 3.7: Number of granules per parasite in extracellular and intracellular 
tachyzoites 
Quantitative analysis for the number of granules was conducted when the parasites were 
grown in complete media (CM) and when they were treated with salubrinal. Granules were 
counted and error bars were obtained for variations using the excel 2013.   
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3.4.2 Effect of cycloheximide and the dynamics of mRNP formation 
Cycloheximide inhibits protein synthesis at the elongation step, and also exhibits an 
ability to disassemble mRNPs from polysomal structures (Mollet et al., 2008). Since the mRNPs 
formed once the parasites were released from the host cells, we tested if cycloheximide has an 
influence on the disassembly and diffusion of those granules. After one hour of incubating 
freshly released tachyzoites in cycloheximide (50 µg/mL), granules were disassembled and 
dispersed in the cytoplasm (Figure 3.8). Treatment with cycloheximide also was applied on the 
intracellular tachyzoites. After two hours incubation period in cycloheximide, TgPABP was 
dispersed in the cytoplasm and similar observation was detected following four hours incubation 
(Figure 3.8). Both salubrinal and cycloheximide inhibit the protein synthesis, but cause an 
opposite effect on the accumulation of mRNP granules. It was then questioned that what effect(s) 
of the combination or switching between these drugs were.  
Since treatment of parasites with salubrinal for two hours induced the formation of 
mRNP granules, we examined whether these mRNPs would dissolve by the subsequent 
treatment with cycloheximide. Smaller granules were observed when media substituted with 
cycloheximide for 30 minutes and mostly diffuse after one hour (Figure 3.9). Also the 
disappearance of mRNPs was observed when salubrinal was replaced by CM for two hours 
(Figure 3.10, middle panel). However, when parasites were treated with cycloheximide first and 
then switched to salubrinal, no granules were detected (Figure 3.10). These findings suggest that 
salubrinal are unlikely to reverse and induce mRNPs granular formation when elongation of 
translation was previously blocked (by cycloheximide) (Figure 3.10).     
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Figure 3.8: Effect of cycloheximide on TgPABP accumulation. 
Following the treatment, freshly lysed tachyzoites were fixed on coverslips followed 
by IFA (Top panel). Images were acquired using a 100x oil objective. Scale bars represent 5 
µm. 
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 Figure 3.9: Disappearance of mRNPs in a time-cross manner. 
(First panel) No granules appeared when intracellular parasites were replicating in complete 
media. (Second panel) When parasites were treated with salubrinal for two hours, mRNPs were 
accumulated in the cytoplasm. (Third to last panel) following the treatment to two hours, 
salubrinal was replaced by cycloheximide for 30 minutes which showed that granules started 
diffusing. After one hour no granules were remained visible (last panel). Images were acquired 
using a 100x oil objective. Scale bars represent 5 µm. 
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Figure 3.10: Disappearance of mRNPs by switching treatments. 
After 24 hours post infection, parasites underwent treatment by salubrinal for two hours then it 
was replaced by either CM or cycloheximide for two hours. Cells were stained with Hoechst 
(blue) to label the nucleus. Images were acquired using a 100x oil objective. Scale bars represent 
5 µm. 
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3.4.3 Effects of actinomycin D on the formation of mRNPs   
To monitor the effects of transcriptional inhibition on mRNPs (containing TgPABP) 
granular formation, actinomycin D (Act D), which is known to bind to DNA and to inhibit the 
binding of RNA polymerase II, was used (Heaslip et al., 2011). Freshly lysed parasites were 
treated with Act D (0.05 µM) for one hour. No changes were observed in term of granular 
formation and localization on extracellular parasites (Figure 3.10). Also, we tested if Act D has 
any impacts on mRNPs on intracellular tachyzoites after two and four hours post treatment. No 
effects on the mRNPs granular formation on the intracellular tachyzoites were observed after two 
and similar observation was seen after four hours (Figure 3.11).   
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Figure 3.11: Effects of Actinomycin D  
Parasites were fixed and stained with Hoechst (blue) to label the nucleus. Images were 
acquired using a 100x oil objective. Scale bars represent 5 µm. 
 
 
 
 
 
  
59 
 
3.4.4 The effect of nutrients starvation  
Ghosh et al. (2012) revealed that starvation of infected host cells alleviates eIF2α-P of 
Toxoplasma, which is an indication for stress, in the intracellular tachyzoites. PABPs were 
showed to be a resident of mRNP stress granules (SGs). Therefore we aimed to monitor the 
formation of TgPABP containing granules to investigate whether the nutrient starvation could 
cause the formation of SGs and TgPABP accumulation. Following the 24 hours post infection, 
infected monolayers were subjected to starvation for 8 hours, by the replacement of complete 
media (CM) with HBSS for starvation. Localization of TgPABP was detected similar to those of 
the control group (Figure 3.12). Similar experimental conditions were used for the transgenic 
parasite strain named TgHoDI-YFP, whose TgHoDI accumulation is indicative of SG formation 
(Cherry and Ananvoranich, 2014). We observed that after two hours incubation in starvation 
media, TgHoDI containing aggregates, namely SGs, increased from one granule per parasite to a 
greater number (Figure 3.13 and Figure 3.14). The number of granules were increased as the 
infected monolayers remained in the starvation longer. In the case of TgPABP, fluorescence of 
tdTomFP were measured for 50 randomly chosen parasites using the ImageJ software. Even 
through images were seen to contain similar phenotypes but the quantifications of fluorescence 
show different pattern (Figure 3.14). One possible reason to explain this variability is that 
tdTomFP has a high rate of photobleatching due to exposing to high excitation (Shaner et al., 
2005). Finally, to compare the localization of TgHoDI containing granules (SGs) at the normal 
life cycle stages to granules that were observed in (Figure 3.5) and also in (Figure 3.13), IFA was 
performed for extra and intracellular tachyzoites and intracellular bradyzoites. Granules were 
localized in cytoplasm in all stages of parasites (Figure 3.15).  
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Figure 3.12: Effect of nutrient starvation on the accumulation and distribution of 
TgPABP. HBSS media lacking glucose were used as starvation media. Also, no granules 
were observed after 2, 4, 6, or 8 hours of incubation in starvation media 
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Figure 3.13: Effect of nutrient starvation on the accumulation of TgHoDI-YFP, a 
marker of stress granules.  
HBSS media lacking glucose were used as starvation media. More granules were observed 
after incubation with HBSS media for 2, 4, and 6 hours; however, less granules were found 
after 8 hours incubation. Images were acquired using a 100x oil objective. Scale bars 
represent 5 µm. 
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Figure 3.14: Quantification of fluorescence of TgPABP-tdTomFP and number of 
granules containing TgHoDI-YFP   
Fluorescence signals of PABP-tdTomFP (TgPABP) and number of granules 
containing HoDI-YFP (TgHoDI) were measured and counted from randomly chosen 
parasites using the ImageJ software. Number of granules (0.1 – 0.4 µm) was counted for 50 
parasites.  Error bars were obtained using the Excel 2013. 
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Figure 3.15: TgHoDI localization 
Parasites were stained with Hoechst (blue) to label the nucleus. Images were acquired using a 
100x oil objective. Scale bars represent 5 µm.  
 
 
 
 
 
64 
 
CHAPTER IV 
DISCUSSION AND CONCLUSION 
 
4.1 Discussion  
  
 Due to a widespread of T. gondii, this pathogen has gained more attention (Ferguson, 
2009). Although the healthy infected individuals show no symptoms, others whose immune 
system are weakened may develop an acute toxoplasmosis that may lead to death. Available 
treatment of toxoplasmosis may cause dangerous side effects. Therefore, many researcher 
focus on studies that may lead to discovery of a new drugs to treat toxoplasmosis. One of 
these studies is on how the gene expression is regulated during the life cycle of Toxoplasma. 
The current study is aimed to localize an important protein in the gene regulation and 
viability of the cell, PABP. PABP binds to mRNAs and involves in the exportation, 
translation, and degradation of the transcripts.  
 Cytosolic isoform of PABP is conserved in most of eukaryotes and Toxoplasma is not 
an exception. Sequence analysis of the amino acids revealed that TgPABP is a homolog of 
cytoplasmic PABP from human, yeast, and other protozoans because of high similarities. The 
CDS of 2310 nucleotides TgPABP yields a protein consisting of 769 residues with a 
predicted molecular weight 82.7 kDa and an isoelectric point of 9.15. Similar to other 
homologs, TgPABP contains four RRMs domains: 82 – 161 (79), 170 – 248 (78), 261 – 329 
(68), and 387 – 466 (79) residues. In comparison to human PABPC1, TgPABP showed 
nearly similar number and types of amino acids which support that TgPABP may have 
similar structure and function of these domains as hPABPC1. One difference however is that 
TgPABP has a long N-terminal before the first RRM (82) while in hPABPC1 there is only 10 
amino acids. This may indicate that TgPABP has another regulatory process. The length of 
human PABC domain is similar to Toxoplasma which is 77 residues spanning from 692 – 
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769. Notably, there is a larger link between the last RRM and PABC. RRMs bind directly to 
the poly (A) tail to enhance the translation and stabilize mRNAs while PABC interacts with 
eRF3 and also it is important in the cellular localization of PABP (Kozlov et al., 2001).  
 PABP is a subject to several post-translational modifications (Brook et al., 2012). 
TgPABP contains multiple serine residues that were predicted to be phosphorylated. 
Interestingly, the majority of these amino acids are located in the functional domains RRMs 
and PABC (Figure 4.1). Phosphorylation of a protein is a mechanism in Toxoplasma and 
Plasmodium to alter the protein activities and eventually cellular function. An example for 
this modification is eIF2α which its phosphorylation leads to stall of translation and enhance 
the formation of mRNP granules (Zhang et al., 2013). Predicted serine residues, subjected to 
phosphorylation, may indicate the possibility of post-translational modifications of TgPABP 
and change in cellular processes.   
 
 
 
 
 
 
 
 
66 
 
MATASPVVAPSSPASAPSQPSPMPASNAGADVPASGTGGHQAAADHTAGNANVGGVSGTTP
APAGQRPNGGMNAGAANFVSPSLYVGDLHQDVTEAMLFEVFNSVGPVTSIRVCRDTVTRRS
LGYAYVNYQGIQDAERSLDTLNYTVIKGQPCRIMWCHRDPSLRKSGNGNIFVKNLDKNIDN
KALYDTFSLFGNILSCKVAVDDNGHSKGYGFVHYENEESARSAIDKVNGMLIGGKTVYVGP
FIRRAERDNLAEAKYTNVYIKNMPSAWEDESRLRETFSKFGSITSLVVRKDPKGRLFAFCN
FADHDSAKAAVEALNGKRVTDAGAIKEGEDSGAEEEKEEEGQKREGDQILFVGPHQSKAHR
SAMLRAKFEQMNQDRNDRFQGVNLYIKNMDDSIDDEKLRQLFEPFGSITSAKVMRDERGVS
RCFGFVCFMSPEEATKAVTEMHLKLVKGKPLYVGLAERREQRLMRLQQRFRLPSLRPAAAA
LPGNVAAAAAAAQLQYGGGAPQLQGFAAGPGAMYAPRPLMGFSPHPHQVTAPMLPWRQQQA
AAAGAQFASQGVPMRPQLGPLQHLYGQTNAAAAAVAAGMHAAAAGGPPMQMLQQQQRGGHR
GGMGRQGGAGPVLNGNKQHMIGPKPGAGQQQPQGGPGSFKFTPQVRNQRLDQQMQPPASVP
APHNHHQVMMEQSQQLLMNPDAPLTAAALAAAQPSMQKQMLGEKLFPLIARYQPELAGKIT
GMMLEMDNAELLILLESEAQLKAKVDEALRVLQQAS 
 
Figure 4.1: Summary of the domains present in TgPABP. 
Five domains are highlighted and indicated with its functional domain.  
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 The strain ∆Ku80∆HX were obtained from Carruther’s lab and used for this study as 
a parental strain. ∆Ku80∆HX lacks the gene Ku80 which functions in the nonhomologous 
recombination repair mechanism of DNA (Huynh and Carruthers, 2009). Furthermore, they 
showed that knock-in of fluorescent proteins does not affect the protein localization (Huynh 
and Carruthers, 2009). The Toxopalsma PABP-tdTomFP strain was successfully generated 
and validated. Addition of the tdTomFP tag (54 kDa) to PABP verified by three methods: 
PCR, western blot, and fluorescence microscopy. This additional tag did not alter the 
TgPABP localization. This observation is supported also by a previous study by Lirussi and 
Matrajt (2011). In their study, a commercial human antibody against TgPABP which share 
88% of the human PABP was used and found that TgPABP accumulates in RNA granules in 
the extracellular parasites.  
 The aim of this dissertation is to use the tagged PABP to study the formation of 
mRNPs. PABP is not only localized in these distinct granules, but also a signal for the 
transcript that actively in the process of translation as it interacts with the 5ʹ cap binding 
protein (eIF4G) to make the closed-loop structure. During the multiplication of tachyzoites in 
PV, PABP was dispersed in the cytoplasm and similar finding were seen also in bradyzoites. 
Distribution of the cytoplasmic PABP revealed the posttranscriptional control of mRNAs and 
their expression. Increasing in the presence of PABP to a subcellular localization may specify 
more regulatory process in this region, the basal end of tachyzoites. Conversely, extracellular 
parasites formed microscopically visible mRNP granules. A previous explanation for the 
formation of mRNPs in extracellular parasites was due to exposure to the host cell 
compartments (Lirussi and Matrajt, 2011). One role of these granules were stated by Lirussi 
and Matrajt (2011) to store mRNAs and increase the parasite viability. These kind of 
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granules were categorized as stress granules that contains untranslated mRNAs and factors of 
the translational machinery. The process of mRNPs formation occurred after the inhibition of 
translation through activation of TgIF2K-D kinase that leads to phosphorylation of eIF2α 
(Konrad et al., 2011; Lirussi and Matrajt, 2011).             
 To validate that stress granules are accumulated in response to cellular stress, 
salubrinal was used to mimic environmental stress. Salubrinal prevents the initiation of 
translation through inhibition of eIF2α-P dephosphorylation (Konrad et al., 2011). No 
changes were observed on the extracellular treated parasites in comparison to non-treated. 
This observation agreed with a previous study identified the effects of salubrinal on 
extracellular tachyzoites (Lirussi and Matrajt, 2011). A novel finding in this study is that 
when intracellular tachyzoites treated with salubrinal for two hours, formation of mRNPs 
granules occurred. As treatment prolonged for further two hours, more granules accumulated 
and enlarged in their sizes. These finding may be display that more untranslated transcripts 
accumulates in these mRNPs for storage or further process. Lirussi and Matrajt (2011) 
demonstrated no mRNAs granules in intracellular parasites which is contradictory to our 
findings. One possible reason is that because they used a human antibody to target TgPABP 
in human cell, the reaction between human PABP and its anti-sera block the visibility of 
Toxoplasma granules.    
 Cycloheximide also inhibits the translation but at further step, elongation. Parasites 
treated with this chemical showed no granules due to another activity of cycloheximide that 
trapping the transcripts in polysomes and dispersed the accumulated mRNP granules Mollet 
et al., 2008). This action was shown clearly on the extracellular parasites when the granules 
completely disappeared.  Further, we used salubrinal and cycloheximide to study the 
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dynamics of mRNPs. CM media reverse the effect of salubrinal but cycloheximide could 
diffuse mRNPs in less than an hour.    
 We also used Act D which is a transcriptional inhibitor. In term of TgPABP 
distribution, there were no changes as TgPABP still dispersed equally in cytoplasm and no 
mRNPs were visualized. Similar observation were demonstrated also in other protozoans, 
Leishmania and Trypanosome, for the cytoplasmic isoform of PABP. Interestingly, these 
organisms encodes multiple PABPs and under treatment of Act D, one isoform was shuttled 
from the cytoplasm to be mainly in the nucleus (Lima et al., 2010). Compared to our result, 
the TgPABP may be a cytoplasmic form and the question whether or not there is another 
nuclear form of PABP is remain to be investigated.    
 Nutrient starvation leads to increase in eIF2α phosphorylation which mediated by 
TgIF2K-C (Konrad et al., 2013). This modification leads to stimulation of the parasite’s 
mitochondrion autophagy and eventually lead to cell death (Ghosh et al., 2011). We 
attempted to repeat this experiment on the PABP-tdTomFP strain to study if there are 
changes in gene regulation during this process. We were not able to detect any mRNP 
granules and PABP was distributed similarly to those non-treated parasites. It is possibly 
because the majority of PABP binds and involves in active translation consequently blocking 
detecting these granules. For this reason we, again, repeated this starvation experiment on the 
parasites expresses TgHoDI-YFP, which more specifically present in these mRNPs (Cherry 
and Ananvoranich, 2014). The finding reflects that there were some regulation of gene 
expression as the number of granules increased as starvation continued.        
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4.1 Conclusion 
 
 All together, the results presented in this thesis, including the sequence analysis and 
poly(A) binding protein and subcellular localization experiments clearly implicate that the 
TgPABP is a cytoplasmic candidate of PABP. mRNPs are formed immediately as parasites 
undergo stresses and TgPABP may play a major role in this mechanism.   
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 CHAPTER V 
FUTURE DIRECTIONS 
 
 The cytoplasmic isoform of PABP is highly conserved protein in all eukaryotes. Even 
though PABPs are vital factors in the regulation of gene expression, in Toxoplasma these 
multifunctional proteins are still to be investigated. In this study, we showed that TgPABP is 
mainly cytoplasmic. Distribution of TgPABP may indicate the active translational process. 
Moreover, under stressful conditions, TgPABP was aggregated in larger cytosolic granules. 
Further functional studies on TgPABP are necessary to understand how gene expression is 
regulated in Toxoplasma. 
 The predicted amino acids sequence of TgPABP showed that it contains many 
residues which possibly are subjected to post-translational modifications (PTM). These 
modifications may have implications on the functions of TgPABP. Brook et al. (2012) 
demonstrated that the human PABPC1 is subject for multiple PTM including methylations of 
glutamate, aspartate, lysine, and arginine, and acetylations of lysine. In Toxoplasma, some of 
these residues are conserved and these predicted modifications may have implications on the 
structural and functional aspects on PABP. Also, it was suggested that the modification status 
of PABP may regulate the formation of mRNPs which regulate the fate of transcripts (Brook 
et al., 2012). 
 In the ToxoDB.org website, it is predicted that only one TgPABP is present in 
Toxoplasma. The finding of present study suggested that TgPABP maybe a cytoplasmic 
isoform. TgPABP was localized in the nucleus and/or prinuclear only when the parasites 
were extracellular or under stresses. In comparison with other protozoans, there are more 
than one isoform of PABP. Also, in the nucleus there should be a PABP to protect the 
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poly(A) tail from degradation. Loss-of-functions experiment is one of the possible 
experiments that may give us a glimpse on whether TgPABP is the only form or not since it 
is important in the viability of the cell. We successfully prepared the plasmid that contained 
TgPABP and a miRNA CDS sequence to study the downregulation of TgPABP expression. 
 To study the dynamics of mRNPs (SGs and P bodies) in Toxoplasma, a hallmark for 
P bodies could be tagged with a fluorescent protein in the PABP-tdTomFP strain. We 
initiated in the cloning procedure to fuse TgDcp2, which is believed to be a hallmark for P 
bodies, with CDS of cyan fluorescent protein.    
 Another protein functions with PABP in regulation of mRNAs in stabilization and 
degradation is eRF3. However, no prediction is shown that Toxoplasma has a homolog for 
the eRF3 protein in the Data bank website for Toxoplasma (ToxoDB.org). We suggest 
further research to identify whether or not there is a homolog for eRF3 protein but it is still 
not updated in the ToxoDB website.        
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APPENDICES 
APPENDIX A 
Table A1: Proteins with high sequence homology to PABPC3 from human  
No. Gene ID (ToxoDB) Annotation 
Score for 
similarities 
to PABPC1   
Molecular 
weight 
1 TGGT1_224850 putative polyadenylate binding protein 427 82699 Da 
2 TGGT1_224580 RNA recognition motif-containing protein 127 54387 Da 
3 TGGT1_264610 RNA recognition motif-containing protein 69.7 45033 Da 
4 TGGT1_310050 RNA recognition motif-containing protein 65.1 44918 Da 
5 TGGT1_320100 RNA recognition motif-containing protein 63.5 128923 Da 
6 TGGT1_292200 RNA recognition motif-containing protein 61.2 222169 Da 
7 TGGT1_272890 RNA recognition motif-containing protein 60.1 48992 Da 
8 TGGT1_318690 RNA recognition motif-containing protein 59.3 124582 Da 
9 TGGT1_321360 clustered-asparagine-rich protein 58.2 30656 Da 
10 TGGT1_203540 putative RNA binding protein 57.4 118702 Da 
11 TGGT1_266740 RNA recognition motif-containing protein 57.0 74177 Da 
12 TGGT1_312530 splicing factor, CC1 family protein 55.8 69357 Da 
13 TGGT1_291930 RNA recognition motif-containing protein 55.5 73132 Da 
14 TGGT1_203080 RNA recognition motif-containing protein 55.1 32725 Da 
15 TGGT1_294670 translation initiation factor 3 subunit 54.3 31813 Da 
16 TGGT1_205180 RNA recognition motif-containing protein 53.1 32011 Da 
17 TGGT1_268200 RNA recognition motif-containing protein 52.0 66431 Da 
18 TGGT1_202770 RNA recognition motif-containing protein 51.6 55869 Da 
19 TGGT1_305010 putative pre-mRNA branch site protein p14 50.8 
17216 Da 
20 TGGT1_265530 RNA recognition motif-containing protein 50.4 51488 Da 
21 TGGT1_262620 RNA recognition motif-containing protein 49.7 31761 Da 
22 TGGT1_270640 RNA recognition motif-containing protein 49.7 24516 Da 
23 TGGT1_283740 RNA recognition motif-containing protein 49.7 64490 Da 
24 TGGT1_321500 RNA recognition motif-containing protein 49.7 50953 Da 
25 TGGT1_254210 RNA recognition motif-containing protein 49.3 114349 Da 
26 TGGT1_234520 U2 snRNP auxilliary factor, large subunit, 
splicing factor subfamily protein 48.1 59962 Da 
27 TGGT1_240070 RNA recognition motif-containing protein 48.1 32075 Da 
28 TGGT1_212190 RNA recognition motif-containing protein 47.8 71952 Da 
29 TGGT1_224720 SPOC domain-containing protein 47.8 73456 Da 
30 TGGT1_268750 putative peptidyl-prolyl cis-trans isomerase E 47.8 
16262 Da 
31 TGGT1_227850 
peptidyl-prolyl cis-trans isomerase, 
cyclophilin-type domain-containing 
protein 
47.0 66239 Da 
32 TGGT1_240710 RNA recognition motif-containing protein 47.0 102082 Da 
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33 TGGT1_272440 RNA recognition motif-containing protein 47.0 23934 Da 
34 TGGT1_223930 RNA recognition motif-containing protein 46.6 40672 Da 
35 TGGT1_211420 RNA recognition motif-containing protein 45.4 22806 Da 
36 TGGT1_283878 RNA recognition motif-containing protein 44.7 72595 Da 
37 TGGT1_209850 RNA recognition motif-containing protein 42.4 170990 Da 
38 TGGT1_289560 RNA recognition motif-containing protein 42.4 30573 Da 
39 TGGT1_309800 RNA recognition motif-containing protein 42.0 41305 Da 
40 TGGT1_321630 RNA recognition motif-containing protein 42.0 45707 Da 
41 TGGT1_306600 RNA recognition motif-containing protein 41.2 21205 Da 
42 TGGT1_215230 RNA recognition motif-containing protein 40.4 80722 Da 
43 TGGT1_215400 RNA recognition motif-containing protein 40.0 41365 Da 
44 TGGT1_254650 zinc finger protein 40.0 44658 Da 
45 TGGT1_218600 RNA recognition motif-containing protein 38.5 84150 Da 
46 TGGT1_270880 RNA recognition motif-containing protein 38.5 138998 Da 
47 TGGT1_291330 RNA recognition motif-containing protein 38.1 25513 Da 
48 TGGT1_305850 RNA recognition motif-containing protein 37.7 39168 Da 
49 TGGT1_319530 splicing factor SF2 37.7 53511 Da 
50 TGGT1_290660 RNA recognition motif-containing protein 37.0 48354 Da 
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Appendix B 
 
 
 
  
 
 
 
Figure B1: Illustration of transgenic plasmid for TgPABP-tdTomFP 
This diagram shows the 3ʹ end coding sequence for PABP gene (TGGT1_224850) from T. gondii
Type I strain. The sequence was obtained from ToxoDB and annotated by the software VNTI
V.10.3.0 (Invitrogen). The LIC primers also are shown.  
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Figure B2: Illustration of transgenic plasmid for TgPABP-SF 
This diagram shows the 3ʹ end coding sequence for PABP gene (TGGT1_224850) from T. gondii
Type I strain. The sequence was obtained from ToxoDB and annotated by the software VNTI 
V.10.3.0 (Invitrogen). The LIC primers also are shown. 
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Figure B3: Illustration of transgenic plasmid for TgPABP-miR60a3X-SF 
This diagram shows the 3ʹ end coding sequence for PABP gene (TGGT1_224850) from T. gondii
Type I strain. The sequence was obtained from ToxoDB and annotated by the software VNTI 
V.10.3.0 (Invitrogen). The LIC primers also are shown. 
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